BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467:1114-1117. [PMID: 20981102 DOI: 10.1038/nature09515] [Cited by in Crossref: 1664] [Cited by in F6Publishing: 1530] [Article Influence: 138.7] [Reference Citation Analysis]
Number Citing Articles
1 Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546-1558. [PMID: 23539594 DOI: 10.1126/science.1235122] [Cited by in Crossref: 4552] [Cited by in F6Publishing: 3999] [Article Influence: 505.8] [Reference Citation Analysis]
2 Hanoun N, Gayral M, Pointreau A, Buscail L, Cordelier P. Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy. Hum Gene Ther. 2016;27:184-192. [PMID: 26731312 DOI: 10.1089/hum.2015.151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
3 Rastogi S, Gulia S, Bajpai J, Ghosh J, Gupta S. Oligometastatic breast cancer: A mini review. Indian J Med Paediatr Oncol 2014;35:203-6. [PMID: 25336790 DOI: 10.4103/0971-5851.142035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
4 Spencer DH, Zhang B, Pfeifer J. Single Nucleotide Variant Detection Using Next Generation Sequencing. Clinical Genomics. Elsevier; 2015. pp. 109-27. [DOI: 10.1016/b978-0-12-404748-8.00008-3] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
5 Sievers CK, Grady WM, Halberg RB, Pickhardt PJ. New insights into the earliest stages of colorectal tumorigenesis. Expert Rev Gastroenterol Hepatol. 2017;11:723-729. [PMID: 28503955 DOI: 10.1080/17474124.2017.1330150] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
6 Liu X, Zheng W, Wang W, Shen H, Liu L, Lou W, Wang X, Yang P. A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline. Br J Cancer. 2017;117:1846-1854. [PMID: 29123261 DOI: 10.1038/bjc.2017.365] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
7 Lu L, Risch HA. Exosomes: potential for early detection in pancreatic cancer. Future Oncol 2016;12:1081-90. [PMID: 26860951 DOI: 10.2217/fon-2015-0005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
8 Nicosia L, Cuccia F, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F, Rigo M, Bonù M, Corradini S, Tolia M, Alongi F. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases. J Cancer Res Clin Oncol 2020;146:2351-8. [PMID: 32356176 DOI: 10.1007/s00432-020-03223-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Coussy F, Bonin F, Azorin P, Tariq Z, Driouch K. [Biology of metastases and molecular mechanisms of their formation]. Bull Cancer 2019;106:24-36. [PMID: 30554635 DOI: 10.1016/j.bulcan.2018.11.010] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Griewank KG, Scolyer RA, Thompson JF, Flaherty KT, Schadendorf D, Murali R. Genetic alterations and personalized medicine in melanoma: progress and future prospects. J Natl Cancer Inst 2014;106:djt435. [PMID: 24511108 DOI: 10.1093/jnci/djt435] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
11 Stevenson RP, Veltman D, Machesky LM. Actin-bundling proteins in cancer progression at a glance. J Cell Sci. 2012;125:1073-1079. [PMID: 22492983 DOI: 10.1242/jcs.093799] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 10.4] [Reference Citation Analysis]
12 Schwarz C, Kaczirek K, Bodingbauer M. Liver resection for non-colorectal metastases. Eur Surg 2018;50:113-6. [PMID: 29875799 DOI: 10.1007/s10353-018-0528-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Modelska A, Quattrone A, Re A. Molecular portraits: the evolution of the concept of transcriptome-based cancer signatures. Brief Bioinform 2015;16:1000-7. [PMID: 25832647 DOI: 10.1093/bib/bbv013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
14 Brouwer A, De Laere B, Peeters D, Peeters M, Salgado R, Dirix L, Van Laere S. Evaluation and consequences of heterogeneity in the circulating tumor cell compartment. Oncotarget. 2016;7:48625-48643. [PMID: 26980749 DOI: 10.18632/oncotarget.8015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
15 Lee SH, Sim SH, Kim JY, Cha S, Song A. Application of cancer genomics to solve unmet clinical needs. Genomics Inform 2013;11:174-9. [PMID: 24465227 DOI: 10.5808/GI.2013.11.4.174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 de Biase D, Genestreti G, Visani M, Acquaviva G, Di Battista M, Cavallo G, Paccapelo A, Cancellieri A, Trisolini R, Degli Esposti R, Bartolini S, Pession A, Tallini G, Brandes AA. The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma. PLoS One 2017;12:e0177822. [PMID: 28520821 DOI: 10.1371/journal.pone.0177822] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Sleeman JP, Christofori G, Fodde R, Collard JG, Berx G, Decraene C, Rüegg C. Concepts of metastasis in flux: the stromal progression model. Semin Cancer Biol 2012;22:174-86. [PMID: 22374376 DOI: 10.1016/j.semcancer.2012.02.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
18 Sun S, Klebaner F, Zhang X, Tian T. Instantaneous mutation rate in cancer initiation and progression. BMC Syst Biol 2018;12:110. [PMID: 30463617 DOI: 10.1186/s12918-018-0629-z] [Reference Citation Analysis]
19 Hardiman KM. Update on Sporadic Colorectal Cancer Genetics. Clin Colon Rectal Surg 2018;31:147-52. [PMID: 29720900 DOI: 10.1055/s-0037-1602234] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
20 Liu X, Li C, Li J, Yu T, Zhou G, Cheng J, Li G, Zhou Y, Lou W, Wang X, Gong G, Liu L, Chen Y. Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer. J Cancer. 2018;9:2038-2045. [PMID: 29896289 DOI: 10.7150/jca.23989] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
21 Matsuda Y, Ishiwata T, Yachida S, Suzuki A, Hamashima Y, Hamayasu H, Yoshimura H, Honma N, Aida J, Takubo K, Arai T. Clinicopathological Features of 15 Occult and 178 Clinical Pancreatic Ductal Adenocarcinomas in 8339 Autopsied Elderly Patients. Pancreas 2016;45:234-40. [DOI: 10.1097/mpa.0000000000000447] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
22 Abdallah R, Taly V, Zhao S, Pietrasz D, Bachet JB, Basile D, Mas L, Zaanan A, Laurent-Puig P, Taieb J. Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review. Cancer Treat Rev 2020;87:102028. [PMID: 32485509 DOI: 10.1016/j.ctrv.2020.102028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
23 Chiou SH, Dorsch M, Kusch E, Naranjo S, Kozak MM, Koong AC, Winslow MM, Grüner BM. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Sci Rep 2018;8:14008. [PMID: 30228296 DOI: 10.1038/s41598-018-32159-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
24 Zhu J, Zhang S, Zhu L, Li X, Wang Y, Duan Y, Huang W. Primary testicular Ph-positive B lymphoblastic lymphoma: an unusual presentation and review. Cancer Biol Ther 2015;16:1122-7. [PMID: 26147907 DOI: 10.1080/15384047.2015.1056412] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
25 Chen S, El-Heliebi A, Kroneis T. Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine? Adv Clin Chem 2017;82:71-103. [PMID: 28939214 DOI: 10.1016/bs.acc.2017.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
26 Tan IB, Malik S, Ramnarayanan K, McPherson JR, Ho DL, Suzuki Y, Ng SB, Yan S, Lim KH, Koh D, Hoe CM, Chan CY, Ten R, Goh BK, Chung AY, Tan J, Chan CX, Tay ST, Alexander L, Nagarajan N, Hillmer AM, Tang CL, Chua C, Teh BT, Rozen S, Tan P. High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer. Genome Biol 2015;16:32. [PMID: 25808843 DOI: 10.1186/s13059-015-0589-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
27 Gao D, Li S. Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases. Cancer Microenviron 2013;6:213-30. [PMID: 24214411 DOI: 10.1007/s12307-013-0138-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
28 Zhai W, Lim TK, Zhang T, Phang ST, Tiang Z, Guan P, Ng MH, Lim JQ, Yao F, Li Z, Ng PY, Yan J, Goh BK, Chung AY, Choo SP, Khor CC, Soon WW, Sung KW, Foo RS, Chow PK. The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma. Nat Commun. 2017;8:4565. [PMID: 28240289 DOI: 10.1038/ncomms14565] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 13.6] [Reference Citation Analysis]
29 Rajamanickam ES, Christians KK, Aldakkak M, Krepline AN, Ritch PS, George B, Erickson BA, Foley WD, Aburajab M, Evans DB, Tsai S. Poor Glycaemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer. J Gastrointest Surg. 2017;21:496-505. [PMID: 27896658 DOI: 10.1007/s11605-016-3319-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
30 Nandy A, Gangopadhyay S, Mukhopadhyay A. Individualizing breast cancer treatment—The dawn of personalized medicine. Experimental Cell Research 2014;320:1-11. [DOI: 10.1016/j.yexcr.2013.09.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
31 Ghatnekar O, Andersson R, Svensson M, Persson U, Ringdahl U, Zeilon P, Borrebaeck CA. Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature. Int J Cancer. 2013;133:2392-2397. [PMID: 23649606 DOI: 10.1002/ijc.28256] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
32 Brown D, Smeets D, Székely B, Larsimont D, Szász AM, Adnet PY, Rothé F, Rouas G, Nagy ZI, Faragó Z, Tőkés AM, Dank M, Szentmártoni G, Udvarhelyi N, Zoppoli G, Pusztai L, Piccart M, Kulka J, Lambrechts D, Sotiriou C, Desmedt C. Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations. Nat Commun 2017;8:14944. [PMID: 28429735 DOI: 10.1038/ncomms14944] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
33 Bühnemann C, Li S, Yu H, Branford White H, Schäfer KL, Llombart-Bosch A, Machado I, Picci P, Hogendoorn PC, Athanasou NA, Noble JA, Hassan AB. Quantification of the heterogeneity of prognostic cellular biomarkers in ewing sarcoma using automated image and random survival forest analysis. PLoS One 2014;9:e107105. [PMID: 25243408 DOI: 10.1371/journal.pone.0107105] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
34 Paterson C, Nowak MA, Waclaw B. An exactly solvable, spatial model of mutation accumulation in cancer. Sci Rep 2016;6:39511. [PMID: 28004754 DOI: 10.1038/srep39511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Sausen M, Phallen J, Adleff V, Jones S, Leary RJ, Barrett MT, Anagnostou V, Parpart-Li S, Murphy D, Kay Li Q, Hruban CA, Scharpf R, White JR, O'Dwyer PJ, Allen PJ, Eshleman JR, Thompson CB, Klimstra DS, Linehan DC, Maitra A, Hruban RH, Diaz LA Jr, Von Hoff DD, Johansen JS, Drebin JA, Velculescu VE. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat Commun. 2015;6:7686. [PMID: 26154128 DOI: 10.1038/ncomms8686] [Cited by in Crossref: 248] [Cited by in F6Publishing: 228] [Article Influence: 35.4] [Reference Citation Analysis]
36 Gupta A, Nandi S, Tiwari S, Choraria A, Chaudhary V. 32 Consecutive Cases of Whipple's Operation with Single-Layer End to Side Dunking Pancreatojejunostomy Without Any Pancreatic Fistula: Our Institutional Experience. Indian J Surg Oncol 2018;9:162-5. [PMID: 29887694 DOI: 10.1007/s13193-017-0707-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Greaves M. Evolutionary determinants of cancer. Cancer Discov. 2015;5:806-820. [PMID: 26193902 DOI: 10.1158/2159-8290.cd-15-0439] [Cited by in Crossref: 215] [Cited by in F6Publishing: 118] [Article Influence: 30.7] [Reference Citation Analysis]
38 Chen F, Ding L. Co-survival of the fittest few: mosaic amplification of receptor tyrosine kinases in glioblastoma. Genome Biol 2012;13:141. [PMID: 22289423 DOI: 10.1186/gb-2012-13-1-141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
39 Kume K, Nishizuka SS. Colony Lysate Arrays for Proteomic Profiling of Drug-Tolerant Persisters of Cancer Cell. Anal Chem 2017;89:8626-31. [PMID: 28753272 DOI: 10.1021/acs.analchem.7b01215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Matthaios D, Zarogoulidis P, Balgouranidou I, Chatzaki E, Kakolyris S. Molecular pathogenesis of pancreatic cancer and clinical perspectives. Oncology. 2011;81:259-272. [PMID: 22116519 DOI: 10.1159/000334449] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
41 Hart PA, Law RJ, Dierkhising RA, Smyrk TC, Takahashi N, Chari ST. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 2014;43:417-421. [PMID: 24622072 DOI: 10.1097/mpa.0000000000000053] [Cited by in Crossref: 61] [Cited by in F6Publishing: 21] [Article Influence: 7.6] [Reference Citation Analysis]
42 Lodestijn SC, van Neerven SM, Vermeulen L, Bijlsma MF. Stem Cells in the Exocrine Pancreas during Homeostasis, Injury, and Cancer. Cancers (Basel) 2021;13:3295. [PMID: 34209288 DOI: 10.3390/cancers13133295] [Reference Citation Analysis]
43 Donahue TR, Tran LM, Hill R, Li Y, Kovochich A, Calvopina JH, Patel SG, Wu N, Hindoyan A, Farrell JJ, Li X, Dawson DW, Wu H. Integrative survival-based molecular profiling of human pancreatic cancer. Clin Cancer Res 2012;18:1352-63. [PMID: 22261810 DOI: 10.1158/1078-0432.CCR-11-1539] [Cited by in Crossref: 131] [Cited by in F6Publishing: 93] [Article Influence: 13.1] [Reference Citation Analysis]
44 Waldmann J, Fendrich V, Reichert M, Hecker A, Bartsch DK, Padberg W, Holler JP. Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancer. Journal of Surgical Research 2018;223:230-6. [DOI: 10.1016/j.jss.2017.11.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
45 Qian Z, Li Y, Sun Z, Fan X, Xu K, Wang K, Li S, Zhang Z, Jiang T, Liu X, Wang Y. Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction. Aging (Albany NY) 2018;10:2884-99. [PMID: 30362964 DOI: 10.18632/aging.101594] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
46 Sato KA, Hachiya T, Iwaya T, Kume K, Matsuo T, Kawasaki K, Abiko Y, Akasaka R, Matsumoto T, Otsuka K. Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel. PLoS One. 2016;11:e0146275. [PMID: 26727500 DOI: 10.1371/journal.pone.0146275] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
47 Li X, Galipeau PC, Paulson TG, Sanchez CA, Arnaudo J, Liu K, Sather CL, Kostadinov RL, Odze RD, Kuhner MK. Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila). 2014;7:114-127. [PMID: 24253313 DOI: 10.1158/1940-6207.CAPR-13-0289] [Cited by in Crossref: 107] [Cited by in F6Publishing: 65] [Article Influence: 11.9] [Reference Citation Analysis]
48 Okaniwa S. How Does Ultrasound Manage Pancreatic Diseases? Ultrasound Findings and Scanning Maneuvers. Gut Liver 2020;14:37-46. [PMID: 31009959 DOI: 10.5009/gnl18567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Sheth RA, Hesketh R, Deipolyi AR, Oklu R. Circulating tumor cells: personalized medicine in interventional oncology? J Vasc Interv Radiol 2013;24:221-8. [PMID: 23265726 DOI: 10.1016/j.jvir.2012.10.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
50 Ottino-Loffler B, Scott JG, Strogatz SH. Evolutionary dynamics of incubation periods. Elife 2017;6:e30212. [PMID: 29266000 DOI: 10.7554/eLife.30212] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
51 Wu Y, Biswas D, Swanton C. Impact of cancer evolution on immune surveillance and checkpoint inhibitor response. Semin Cancer Biol 2021:S1044-579X(21)00042-0. [PMID: 33631295 DOI: 10.1016/j.semcancer.2021.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Eckert MA, Pan S, Hernandez KM, Loth RM, Andrade J, Volchenboum SL, Faber P, Montag A, Lastra R, Peter ME, Yamada SD, Lengyel E. Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube. Cancer Discov 2016;6:1342-51. [PMID: 27856443 DOI: 10.1158/2159-8290.CD-16-0607] [Cited by in Crossref: 111] [Cited by in F6Publishing: 60] [Article Influence: 18.5] [Reference Citation Analysis]
53 Swanton C. Cancer evolution: the final frontier of precision medicine? Ann Oncol. 2014;25:549-551. [PMID: 24567514 DOI: 10.1093/annonc/mdu005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
54 Stan SD, Singh SV, Whitcomb DC, Brand RE. Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model. Nutr Cancer 2014;66:747-55. [PMID: 24195616 DOI: 10.1080/01635581.2013.795979] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
55 Sagami R, Yamao K, Nakahodo J, Minami R, Tsurusaki M, Murakami K, Amano Y. Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma. Cancers (Basel) 2021;13:945. [PMID: 33668239 DOI: 10.3390/cancers13050945] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Blagosklonny MV. NCI's provocative questions on cancer: some answers to ignite discussion. Oncotarget 2011;2:1352-67. [PMID: 22267462 DOI: 10.18632/oncotarget.432] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
57 Kanji ZS, Gallinger S. Diagnosis and management of pancreatic cancer. CMAJ. 2013;185:1219-1226. [PMID: 23610017 DOI: 10.1503/cmaj.121368] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
58 Mohammed A, Janakiram NB, Pant S, Rao CV. Molecular Targeted Intervention for Pancreatic Cancer. Cancers (Basel) 2015;7:1499-542. [PMID: 26266422 DOI: 10.3390/cancers7030850] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
59 Roth A, Ding J, Morin R, Crisan A, Ha G, Giuliany R, Bashashati A, Hirst M, Turashvili G, Oloumi A, Marra MA, Aparicio S, Shah SP. JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics 2012;28:907-13. [PMID: 22285562 DOI: 10.1093/bioinformatics/bts053] [Cited by in Crossref: 130] [Cited by in F6Publishing: 106] [Article Influence: 13.0] [Reference Citation Analysis]
60 Hu P, Chen X, Sun J, Bie P, Zhang LD. siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo. Biosci Rep 2015;35:e00170. [PMID: 25370920 DOI: 10.1042/BSR20140124] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
61 Nicolini A, Ferrari P, Rossi G, Carpi A. Tumour growth and immune evasion as targets for a new strategy in advanced cancer. Endocr Relat Cancer 2018;25:R577–R604. [PMID: 30306784 DOI: 10.1530/ERC-18-0142] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
62 Zhang S, Xia B, Jiang H, Wang L, Xu R, Shi Y, Zhang J, Xu M, Cram DS, Ma S. Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology. Oncotarget 2016;7:50477-89. [DOI: 10.18632/oncotarget.10464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
63 Poruk KE, Firpo MA, Mulvihill SJ. Screening for pancreatic cancer. Adv Surg 2014;48:115-36. [PMID: 25293611 DOI: 10.1016/j.yasu.2014.05.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
64 Chambers AF, Werb Z. Invasion and metastasis--recent advances and future challenges. J Mol Med (Berl) 2015;93:361-8. [PMID: 25772709 DOI: 10.1007/s00109-015-1269-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
65 Perry EB, Makohon-Moore A, Zheng C, Kaufman CK, Cai J, Iacobuzio-Donahue CA, White RM. Tumor diversity and evolution revealed through RADseq. Oncotarget 2017;8:41792-805. [PMID: 28611298 DOI: 10.18632/oncotarget.18355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
66 Michaud DS, Izard J. Microbiota, oral microbiome, and pancreatic cancer. Cancer J 2014;20:203-6. [PMID: 24855008 DOI: 10.1097/PPO.0000000000000046] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 8.9] [Reference Citation Analysis]
67 Winterhoff B, Talukdar S, Chang Z, Wang J, Starr TK. Single-cell sequencing in ovarian cancer: a new frontier in precision medicine. Current Opinion in Obstetrics & Gynecology 2019;31:49-55. [DOI: 10.1097/gco.0000000000000516] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
68 Sinha A, Cherba D, Bartlam H, Lenkiewicz E, Evers L, Barrett MT, Haab BB. Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts. Mol Oncol 2014;8:1253-65. [PMID: 24837184 DOI: 10.1016/j.molonc.2014.04.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
69 Pfeifer JD. Identity determination in diagnostic surgical pathology. Semin Diagn Pathol 2019;36:355-65. [PMID: 31196743 DOI: 10.1053/j.semdp.2019.06.001] [Reference Citation Analysis]
70 Huang F, Tang J, Zhuang X, Zhuang Y, Cheng W, Chen W, Yao H, Zhang S. MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha. PLoS One. 2014;9:e87897. [PMID: 24504166 DOI: 10.1371/journal.pone.0087897] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 8.1] [Reference Citation Analysis]
71 Imamura T, Komatsu S, Ichikawa D, Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H, Shiozaki A, Morimura R, Ikoma H, Okamoto K, Otsuji E. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. World J Gastroenterol 2016; 22(25): 5627-5641 [PMID: 27433079 DOI: 10.3748/wjg.v22.i25.5627] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
72 Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, Laird PW, Onofrio RC, Winckler W, Weir BA, Beroukhim R, Pellman D, Levine DA, Lander ES, Meyerson M, Getz G. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30:413-421. [PMID: 22544022 DOI: 10.1038/nbt.2203] [Cited by in Crossref: 1166] [Cited by in F6Publishing: 999] [Article Influence: 116.6] [Reference Citation Analysis]
73 Wennerström AB, Lothe IM, Sandhu V, Kure EH, Myklebost O, Munthe E. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS One 2014;9:e103873. [PMID: 25148029 DOI: 10.1371/journal.pone.0103873] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
74 Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med. 2011;17:313-319. [PMID: 21386835 DOI: 10.1038/nm.2304] [Cited by in Crossref: 1241] [Cited by in F6Publishing: 1135] [Article Influence: 112.8] [Reference Citation Analysis]
75 Sanborn JZ, Chung J, Purdom E, Wang NJ, Kakavand H, Wilmott JS, Butler T, Thompson JF, Mann GJ, Haydu LE, Saw RP, Busam KJ, Lo RS, Collisson EA, Hur JS, Spellman PT, Cleaver JE, Gray JW, Huh N, Murali R, Scolyer RA, Bastian BC, Cho RJ. Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination. Proc Natl Acad Sci U S A 2015;112:10995-1000. [PMID: 26286987 DOI: 10.1073/pnas.1508074112] [Cited by in Crossref: 105] [Cited by in F6Publishing: 81] [Article Influence: 15.0] [Reference Citation Analysis]
76 Schawkat K, Kühn W, Inderbitzin D, Gloor B, Heverhagen JT, Runge VM, Christe A. Diagnostic Value and Interreader Agreement of the Pancreaticolienal Gap in Pancreatic Cancer on MDCT. PLoS One 2016;11:e0166003. [PMID: 27893776 DOI: 10.1371/journal.pone.0166003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
77 Muralidhar V, Nipp RD, Mamon HJ, Punglia RS, Hong TS, Ferrone C, Fernandez-Del Castillo C, Parikh A, Nguyen PL, Wo JY. Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer. Ann Surg Oncol 2018;25:4027-34. [PMID: 30298331 DOI: 10.1245/s10434-018-6832-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
78 Paterlini-Bréchot P. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy. Future Oncol 2011;7:849-71. [PMID: 21732757 DOI: 10.2217/fon.11.32] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
79 Masugi Y, Yamazaki K, Emoto K, Effendi K, Tsujikawa H, Kitago M, Itano O, Kitagawa Y, Sakamoto M. Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma. Lab Invest. 2015;95:308-319. [PMID: 25599535 DOI: 10.1038/labinvest.2014.166] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
80 Anagnostou V, Smith KN, Forde PM, Niknafs N, Bhattacharya R, White J, Zhang T, Adleff V, Phallen J, Wali N, Hruban C, Guthrie VB, Rodgers K, Naidoo J, Kang H, Sharfman W, Georgiades C, Verde F, Illei P, Li QK, Gabrielson E, Brock MV, Zahnow CA, Baylin SB, Scharpf RB, Brahmer JR, Karchin R, Pardoll DM, Velculescu VE. Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. Cancer Discov 2017;7:264-76. [PMID: 28031159 DOI: 10.1158/2159-8290.CD-16-0828] [Cited by in Crossref: 402] [Cited by in F6Publishing: 278] [Article Influence: 67.0] [Reference Citation Analysis]
81 Zandberg DP, Tallon LJ, Nagaraj S, Sadzewicz LK, Zhang Y, Strome MB, Zhao XE, Vavikolanu K, Zhang X, Papadimitriou JC, Hubbard FA, Bentzen SM, Strome SE, Fraser CM. Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity. Head Neck 2019;41:2514-24. [PMID: 30869813 DOI: 10.1002/hed.25719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
82 Chen MY, Gillanders WE. Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound. Breast Cancer (Dove Med Press) 2021;13:311-23. [PMID: 34040436 DOI: 10.2147/BCTT.S273039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Koay EJ, Amer AM, Baio FE, Ondari AO, Fleming JB. Toward stratification of patients with pancreatic cancer: Past lessons from traditional approaches and future applications with physical biomarkers. Cancer Lett. 2016; Epub ahead of print. [PMID: 26806807 DOI: 10.1016/j.canlet.2015.12.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
84 Hurst DR, Welch DR. Metastasis suppressor genes at the interface between the environment and tumor cell growth. Int Rev Cell Mol Biol 2011;286:107-80. [PMID: 21199781 DOI: 10.1016/B978-0-12-385859-7.00003-3] [Cited by in Crossref: 85] [Cited by in F6Publishing: 60] [Article Influence: 7.7] [Reference Citation Analysis]
85 Phay JE, Ringel MD. Metastatic mechanisms in follicular cell-derived thyroid cancer. Endocr Relat Cancer 2013;20:R307-19. [PMID: 24036131 DOI: 10.1530/ERC-13-0187] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
86 Husain K, Coppola D, Yang CS, Malafa MP. Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis. Sci Rep 2021;11:2185. [PMID: 33500430 DOI: 10.1038/s41598-020-80911-z] [Reference Citation Analysis]
87 Ryu JK, Matthaei H, Dal Molin M, Hong SM, Canto MI, Schulick RD, Wolfgang C, Goggins MG, Hruban RH, Cope L. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology. 2011;11:343-350. [PMID: 21757972 DOI: 10.1159/000329183] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 7.5] [Reference Citation Analysis]
88 Lynch SM, Major JM, Cawthon R, Weinstein SJ, Virtamo J, Lan Q, Rothman N, Albanes D, Stolzenberg-Solomon RZ. A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study. Int J Cancer 2013;133:2672-80. [PMID: 23674344 DOI: 10.1002/ijc.28272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 36] [Article Influence: 0.7] [Reference Citation Analysis]
89 Chee J, Liu X, Eu D, Loh T, Ho F, Wong LC, Tham I, Tan CS, Goh BC, Lim CM. Defining a cohort of oligometastatic nasopharyngeal carcinoma patients with improved clinical outcomes. Head & Neck 2020;42:945-54. [DOI: 10.1002/hed.26061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
90 Sehn JK, Spencer DH, Pfeifer JD, Bredemeyer AJ, Cottrell CE, Abel HJ, Duncavage EJ. Occult Specimen Contamination in Routine Clinical Next-Generation Sequencing Testing. American Journal of Clinical Pathology 2015;144:667-74. [DOI: 10.1309/ajcpr88wdjjldmbn] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
91 Neesse A, Hahnenkamp A, Griesmann H, Buchholz M, Hahn SA, Maghnouj A, Fendrich V, Ring J, Sipos B, Tuveson DA, Bremer C, Gress TM, Michl P. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. Gut. 2013;62:1034-1043. [PMID: 22677720 DOI: 10.1136/gutjnl-2012-302577] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
92 Felsenstein M, Hruban RH, Wood LD. New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis. Adv Anat Pathol. 2018;25:131-142. [PMID: 28914620 DOI: 10.1097/pap.0000000000000172] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
93 Frič P, Šedo A, Škrha J, Bušek P, Laclav M, Škrha P, Zavoral M. Early detection of sporadic pancreatic cancer: time for change. European Journal of Gastroenterology & Hepatology 2017;29:885-91. [DOI: 10.1097/meg.0000000000000904] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
94 Goswami RS, Patel KP, Singh RR, Meric-Bernstam F, Kopetz ES, Subbiah V, Alvarez RH, Davies MA, Jabbar KJ, Roy-Chowdhuri S, Lazar AJ, Medeiros LJ, Broaddus RR, Luthra R, Routbort MJ. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors. Clin Cancer Res 2015;21:2644-51. [PMID: 25695693 DOI: 10.1158/1078-0432.CCR-14-2391] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 7.9] [Reference Citation Analysis]
95 Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 2012;21:283-96. [PMID: 22439924 DOI: 10.1016/j.ccr.2012.03.003] [Cited by in Crossref: 769] [Cited by in F6Publishing: 767] [Article Influence: 76.9] [Reference Citation Analysis]
96 Duregon E, Schneider J, DeMarzo AM, Hooper JE. Rapid research autopsy is a stealthy but growing contributor to cancer research. Cancer 2019;125:2915-9. [PMID: 31090935 DOI: 10.1002/cncr.32184] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
97 Patel SA, Rodrigues P, Wesolowski L, Vanharanta S. Genomic control of metastasis. Br J Cancer 2021;124:3-12. [PMID: 33144692 DOI: 10.1038/s41416-020-01127-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
98 Nauck MA, Friedrich N. Do GLP-1-based therapies increase cancer risk? Diabetes Care 2013;36 Suppl 2:S245-52. [PMID: 23882053 DOI: 10.2337/dcS13-2004] [Cited by in Crossref: 75] [Cited by in F6Publishing: 38] [Article Influence: 9.4] [Reference Citation Analysis]
99 Busch SJ, Hoffmann P, Sahota P, Johnson R, Kothny W, Meyer F, Foley JE. Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man. Diabetes Obes Metab 2013;15:72-6. [PMID: 22882290 DOI: 10.1111/j.1463-1326.2012.01678.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
100 Benesova L, Belsanova B, Suchanek S, Kopeckova M, Minarikova P, Lipska L, Levy M, Visokai V, Zavoral M, Minarik M. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients. Anal Biochem. 2013;433:227-234. [PMID: 22750103 DOI: 10.1016/j.ab.2012.06.018] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
101 Yamao K, Takenaka M, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Omoto S, Kamata K, Minaga K, Matsumoto I, Takeyama Y, Numoto I, Tsurusaki M, Chikugo T, Chiba Y, Watanabe T, Kudo M. Partial Pancreatic Parenchymal Atrophy Is a New Specific Finding to Diagnose Small Pancreatic Cancer (≤10 mm) Including Carcinoma in Situ: Comparison with Localized Benign Main Pancreatic Duct Stenosis Patients. Diagnostics (Basel) 2020;10:E445. [PMID: 32630180 DOI: 10.3390/diagnostics10070445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
102 Caldas C. Cancer sequencing unravels clonal evolution. Nat Biotechnol 2012;30:408-10. [PMID: 22565966 DOI: 10.1038/nbt.2213] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
103 Hu D, Ansari D, Pawłowski K, Zhou Q, Sasor A, Welinder C, Kristl T, Bauden M, Rezeli M, Jiang Y, Marko-Varga G, Andersson R. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. Oncotarget 2018;9:9789-807. [PMID: 29515771 DOI: 10.18632/oncotarget.23929] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
104 Lou X, Li J, Wei YQ, Jiang ZJ, Chen M, Sun JJ. Comparable prevalence of distant metastasis and survival of different primary site for LN + pancreatic tumor. J Transl Med 2020;18:266. [PMID: 32611358 DOI: 10.1186/s12967-020-02438-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Alessandrino F, Smith DA, Tirumani SH, Ramaiya NH. Cancer genome landscape: a radiologist's guide to cancer genome medicine with imaging correlates. Insights Imaging 2019;10:111. [PMID: 31781977 DOI: 10.1186/s13244-019-0800-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
106 Liu Y, Kaur S, Huang Y, Fahrmann JF, Rinaudo JA, Hanash SM, Batra SK, Singhi AD, Brand RE, Maitra A, Haab BB. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN. Cancer Epidemiol Biomarkers Prev 2020;29:2513-23. [PMID: 32532830 DOI: 10.1158/1055-9965.EPI-20-0161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
107 Swanton C, McGranahan N, Starrett GJ, Harris RS. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity. Cancer Discov 2015;5:704-12. [PMID: 26091828 DOI: 10.1158/2159-8290.CD-15-0344] [Cited by in Crossref: 246] [Cited by in F6Publishing: 161] [Article Influence: 35.1] [Reference Citation Analysis]
108 Kriz D, Ansari D, Andersson R. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2020;22:2170-2174. [PMID: 32447642 DOI: 10.1007/s12094-020-02372-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Rocker JM, Tan MC, Thompson LW, Contreras CM, DiPalma JA, Pannell LK. Comparative Proteomic Analysis of Whole-Gut Lavage Fluid and Pancreatic Juice Reveals a Less Invasive Method of Sampling Pancreatic Secretions. Clin Transl Gastroenterol 2016;7:e174. [PMID: 27228405 DOI: 10.1038/ctg.2016.27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
110 Kumar A, Coleman I, Morrissey C, Zhang X, True LD, Gulati R, Etzioni R, Bolouri H, Montgomery B, White T, Lucas JM, Brown LG, Dumpit RF, DeSarkar N, Higano C, Yu EY, Coleman R, Schultz N, Fang M, Lange PH, Shendure J, Vessella RL, Nelson PS. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat Med 2016;22:369-78. [PMID: 26928463 DOI: 10.1038/nm.4053] [Cited by in Crossref: 381] [Cited by in F6Publishing: 345] [Article Influence: 63.5] [Reference Citation Analysis]
111 Youn A, Simon R. Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations. BMC Bioinformatics 2013;14:363. [PMID: 24330428 DOI: 10.1186/1471-2105-14-363] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
112 Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607-620. [PMID: 21620466 DOI: 10.1016/so140-6736(10)62307-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Nguyen AV, Nyberg KD, Scott MB, Welsh AM, Nguyen AH, Wu N, Hohlbauch SV, Geisse NA, Gibb EA, Robertson AG, Donahue TR, Rowat AC. Stiffness of pancreatic cancer cells is associated with increased invasive potential. Integr Biol (Camb) 2016;8:1232-45. [PMID: 27761545 DOI: 10.1039/c6ib00135a] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 9.2] [Reference Citation Analysis]
114 Iliou A, Panagiotakis A, Giannopoulou AF, Benaki D, Kosmopoulou M, Velentzas AD, Tsitsilonis OE, Papassideri IS, Voutsinas GE, Konstantakou EG, Gikas E, Mikros E, Stravopodis DJ. Malignancy Grade-Dependent Mapping of Metabolic Landscapes in Human Urothelial Bladder Cancer: Identification of Novel, Diagnostic, and Druggable Biomarkers. Int J Mol Sci 2020;21:E1892. [PMID: 32164285 DOI: 10.3390/ijms21051892] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Sabzpoushan SH. A System Biology-Based Approach for Designing Combination Therapy in Cancer Precision Medicine. Biomed Res Int 2020;2020:5072697. [PMID: 32908895 DOI: 10.1155/2020/5072697] [Reference Citation Analysis]
116 Burns EA, Kasparian S, Khan U, Abdelrahim M. Pancreatic adenocarcinoma with early esophageal metastasis: A case report and review of literature. World J Clin Oncol 2020; 11(2): 83-90 [PMID: 32133277 DOI: 10.5306/wjco.v11.i2.83] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Burkhart RA, Pineda DM, Chand SN, Romeo C, Londin ER, Karoly ED, Cozzitorto JA, Rigoutsos I, Yeo CJ, Brody JR, Winter JM. HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer. RNA Biol. 2013;10:1312-1323. [PMID: 23807417 DOI: 10.4161/rna.25274] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
118 Ito Y, Maeda D, Yoshida M, Yoshida A, Kudo-asabe Y, Nanjyo H, Izumi C, Yamamoto F, Inoue M, Shibata H, Katoh H, Ishikawa S, Nakamura H, Totoki Y, Shibata T, Yachida S, Goto A. Cardiac intimal sarcoma with PDGFRβ mutation and co-amplification of PDGFRα and MDM2: an autopsy case analyzed by whole-exome sequencing. Virchows Arch 2017;471:423-8. [DOI: 10.1007/s00428-017-2135-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
119 Botesteanu DA, Lee JM, Levy D. Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early Detection. PLoS One 2016;11:e0156661. [PMID: 27257824 DOI: 10.1371/journal.pone.0156661] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
120 Zhu P, Fan Z. Cancer stem cells and tumorigenesis. Biophys Rep 2018;4:178-88. [PMID: 30310855 DOI: 10.1007/s41048-018-0062-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
121 Huynh DL, Koh H, Chandimali N, Zhang JJ, Kim N, Kang TY, Ghosh M, Gera M, Park YH, Kwon T, Jeong DK. BRM270 Inhibits the Proliferation of CD44 Positive Pancreatic Ductal Adenocarcinoma Cells via Downregulation of Sonic Hedgehog Signaling. Evid Based Complement Alternat Med 2019;2019:8620469. [PMID: 31049070 DOI: 10.1155/2019/8620469] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
122 Chhoda A, Lu L, Clerkin BM, Risch H, Farrell JJ. Current approaches to pancreatic cancer screening. Am J Pathol. 2019;189:22-35. [PMID: 30558719 DOI: 10.1016/j.ajpath.2018.09.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
123 Sun J, Li Y, Liu L, Jiang Z, Liu G. Aspirin use and pancreatic cancer risk: A systematic review of observational studies. Medicine (Baltimore) 2019;98:e18033. [PMID: 31860953 DOI: 10.1097/MD.0000000000018033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
124 Daneshmand M, Hanson JE, Nabavi M, Hilton JF, Vandermeer L, Kanji F, Dent SF, Clemons M, Lorimer IA. Detection of PIK3CA Mutations in Breast Cancer Bone Metastases. ISRN Oncol 2012;2012:492578. [PMID: 22970388 DOI: 10.5402/2012/492578] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
125 Ren SC, Qu M, Sun YH. Investigating intratumour heterogeneity by single-cell sequencing. Asian J Androl 2013;15:729-34. [PMID: 24141534 DOI: 10.1038/aja.2013.106] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
126 Talbert EE, Cuitiño MC, Ladner KJ, Rajasekerea PV, Siebert M, Shakya R, Leone GW, Ostrowski MC, Paleo B, Weisleder N, Reiser PJ, Webb A, Timmers CD, Eiferman DS, Evans DC, Dillhoff ME, Schmidt CR, Guttridge DC. Modeling Human Cancer-induced Cachexia. Cell Rep 2019;28:1612-1622.e4. [PMID: 31390573 DOI: 10.1016/j.celrep.2019.07.016] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 20.5] [Reference Citation Analysis]
127 Kloosterman WP, Hoogstraat M, Paling O, Tavakoli-Yaraki M, Renkens I, Vermaat JS, van Roosmalen MJ, van Lieshout S, Nijman IJ, Roessingh W, van 't Slot R, van de Belt J, Guryev V, Koudijs M, Voest E, Cuppen E. Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer. Genome Biol. 2011;12:R103. [PMID: 22014273 DOI: 10.1186/gb-2011-12-10-r103] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 11.5] [Reference Citation Analysis]
128 Keats JJ, Chesi M, Egan JB, Garbitt VM, Palmer SE, Braggio E, Van Wier S, Blackburn PR, Baker AS, Dispenzieri A, Kumar S, Rajkumar SV, Carpten JD, Barrett M, Fonseca R, Stewart AK, Bergsagel PL. Clonal competition with alternating dominance in multiple myeloma. Blood. 2012;120:1067-1076. [PMID: 22498740 DOI: 10.1182/blood-2012-01-405985] [Cited by in Crossref: 424] [Cited by in F6Publishing: 395] [Article Influence: 42.4] [Reference Citation Analysis]
129 Fukushima D, Nishino N, Hamada K, Horikawa Y, Shiwa Y, Nishida S, Koyanagi R, Abe T, Suzuki N, Takano Y, Teranishi Y, Munechika H, Miura Y, Nakasato T, Sakuma H. Characteristic Radiological Features of Retrospectively Diagnosed Pancreatic Cancers. Pancreas 2020;49:76-88. [PMID: 31856082 DOI: 10.1097/MPA.0000000000001456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Aravindhan S, Younus LA, Hadi Lafta M, Markov A, Ivanovna Enina Y, Yushchenkо NA, Thangavelu L, Mostafavi SM, Pokrovskii MV, Ahmadi M. P53 long noncoding RNA regulatory network in cancer development. Cell Biol Int 2021;45:1583-98. [PMID: 33760334 DOI: 10.1002/cbin.11600] [Reference Citation Analysis]
131 An Y, Zhao J, Zhang Y, Wu W, Hu J, Hao H, Qiao Y, Tao Y, An L. Rosmarinic Acid Induces Proliferation Suppression of Hepatoma Cells Associated with NF-κB Signaling Pathway. Asian Pac J Cancer Prev 2021;22:1623-32. [PMID: 34048194 DOI: 10.31557/APJCP.2021.22.5.1623] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Asting AG, Ljungman D, Carén H, Dambrauskas Z, Iresjö BM, Hyltander A, Naredi P, Lundholm K. Alterations in Tumor DNA Are Related to Short Postoperative Survival in Patients Resected for Pancreatic Carcinoma Aimed at Cure. Pancreas 2016;45:900-7. [PMID: 26684859 DOI: 10.1097/MPA.0000000000000566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
133 Brancaccio M, Natale F, Falco G, Angrisano T. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery. Genes (Basel) 2019;11:E14. [PMID: 31877923 DOI: 10.3390/genes11010014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
134 Kimura K, Huang RC. Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01. PLoS One 2016;11:e0148685. [PMID: 26886430 DOI: 10.1371/journal.pone.0148685] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
135 Hlavac V, Mohelnikova-Duchonova B, Lovecek M, Ehrmann J, Brynychova V, Kolarova K, Soucek P. Targeted Sequencing of Pancreatic Adenocarcinomas from Patients with Metachronous Pulmonary Metastases. Genes (Basel) 2020;11:E1391. [PMID: 33255265 DOI: 10.3390/genes11121391] [Reference Citation Analysis]
136 Graham JS, Jamieson NB, Rulach R, Grimmond SM, Chang DK, Biankin AV. Pancreatic cancer genomics: where can the science take us? Clin Genet 2015;88:213-9. [PMID: 25388820 DOI: 10.1111/cge.12536] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
137 Shimizu K, Chiba S, Hori Y. Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients. PLoS One 2013;8:e81283. [PMID: 24278411 DOI: 10.1371/journal.pone.0081283] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
138 Haage A, Schneider IC. Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells. FASEB J 2014;28:3589-99. [PMID: 24784579 DOI: 10.1096/fj.13-245613] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 8.9] [Reference Citation Analysis]
139 Steeg PS. Targeting metastasis. Nat Rev Cancer 2016;16:201-18. [PMID: 27009393 DOI: 10.1038/nrc.2016.25] [Cited by in Crossref: 671] [Cited by in F6Publishing: 637] [Article Influence: 111.8] [Reference Citation Analysis]
140 Hiley C, de Bruin EC, McGranahan N, Swanton C. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine. Genome Biol 2014;15:453. [PMID: 25222836 DOI: 10.1186/s13059-014-0453-8] [Cited by in Crossref: 132] [Cited by in F6Publishing: 124] [Article Influence: 16.5] [Reference Citation Analysis]
141 Barreto SG. Does biology determine survival in pancreatic cancer? Future Oncol 2020;16:1-4. [PMID: 31872770 DOI: 10.2217/fon-2019-0706] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
142 Aryee MJ, Liu W, Engelmann JC, Nuhn P, Gurel M, Haffner MC, Esopi D, Irizarry RA, Getzenberg RH, Nelson WG, Luo J, Xu J, Isaacs WB, Bova GS, Yegnasubramanian S. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci Transl Med. 2013;5:169ra10. [PMID: 23345608 DOI: 10.1126/scitranslmed.3005211] [Cited by in Crossref: 168] [Cited by in F6Publishing: 162] [Article Influence: 18.7] [Reference Citation Analysis]
143 Cirkel GA, Gadellaa-van Hooijdonk CG, Koudijs MJ, Willems SM, Voest EE. Tumor heterogeneity and personalized cancer medicine: are we being outnumbered? Future Oncol 2014;10:417-28. [PMID: 24559448 DOI: 10.2217/fon.13.214] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
144 Qian Y, Li J, Xia S. ZNF281 Promotes Growth and Invasion of Pancreatic Cancer Cells by Activating Wnt/β-Catenin Signaling. Dig Dis Sci 2017;62:2011-20. [PMID: 28523575 DOI: 10.1007/s10620-017-4611-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
145 Gharibi A, Adamian Y, Kelber JA. Cellular and molecular aspects of pancreatic cancer. Acta Histochem 2016;118:305-16. [PMID: 26868366 DOI: 10.1016/j.acthis.2016.01.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
146 Ansari D, Chen BC, Dong L, Zhou MT, Andersson R. Pancreatic cancer: Translational research aspects and clinical implications. World J Gastroenterol 2012; 18(13): 1417-1424 [PMID: 22509073 DOI: 10.3748/wjg.v18.i13.1417] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
147 Poruk KE, Firpo MA, Adler DG, Mulvihill SJ. Screening for pancreatic cancer: why, how, and who? Ann Surg 2013;257:17-26. [PMID: 22895395 DOI: 10.1097/SLA.0b013e31825ffbfb] [Cited by in Crossref: 120] [Cited by in F6Publishing: 64] [Article Influence: 13.3] [Reference Citation Analysis]
148 Corvigno S, Wisman GB, Mezheyeuski A, van der Zee AG, Nijman HW, Åvall-Lundqvist E, Östman A, Dahlstrand H. Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival. Oncotarget 2016;7:18573-84. [PMID: 26918345 DOI: 10.18632/oncotarget.7613] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
149 Morisaki T, Umebayashi M, Kiyota A, Koya N, Tanaka H, Onishi H, Katano M. Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro. Anticancer Res. 2012;32:2249-2256. [PMID: 22641659 DOI: 10.1016/j.semcancer.2012.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
150 Thu KL, Radulovich N, Becker-Santos DD, Pikor LA, Pusic A, Lockwood WW, Lam WL, Tsao MS. SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling. Oncogene. 2014;33:279-288. [PMID: 23318427 DOI: 10.1038/onc.2012.595] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
151 Fertig EJ, Ozawa H, Thakar M, Howard JD, Kagohara LT, Krigsfeld G, Ranaweera RS, Hughes RM, Perez J, Jones S, Favorov AV, Carey J, Stein-O'Brien G, Gaykalova DA, Ochs MF, Chung CH. CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network. Oncotarget 2016;7:73845-64. [PMID: 27650546 DOI: 10.18632/oncotarget.12075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
152 Patel SA, Vanharanta S. Epigenetic determinants of metastasis. Mol Oncol 2017;11:79-96. [PMID: 27756687 DOI: 10.1016/j.molonc.2016.09.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
153 Panebianco C, Villani A, Pazienza V. High Levels of Prebiotic Resistant Starch in Diet Modulate Gene Expression and Metabolomic Profile in Pancreatic Cancer Xenograft Mice. Nutrients 2019;11:E709. [PMID: 30934731 DOI: 10.3390/nu11040709] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
154 Duesberg P, Iacobuzio-Donahue C, Brosnan JA, McCormack A, Mandrioli D, Chen L. Origin of metastases: subspecies of cancers generated by intrinsic karyotypic variations. Cell Cycle 2012;11:1151-66. [PMID: 22377695 DOI: 10.4161/cc.11.6.19580] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
155 Du Y, Lu T, Huang S, Ren F, Cui G, Chen J. Somatic mutation landscape of a meningioma and its pulmonary metastasis. Cancer Commun (Lond) 2018;38:16. [PMID: 29764516 DOI: 10.1186/s40880-018-0291-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
156 Kaur S, Baine MJ, Jain M, Sasson AR, Batra SK. Early diagnosis of pancreatic cancer: challenges and new developments. Biomark Med. 2012;6:597-612. [PMID: 23075238 DOI: 10.2217/bmm.12.69] [Cited by in Crossref: 118] [Cited by in F6Publishing: 107] [Article Influence: 13.1] [Reference Citation Analysis]
157 Chiaro MD, Segersvärd R, Lohr M, Verbeke C. Early detection and prevention of pancreatic cancer: Is it really possible today? World J Gastroenterol 2014; 20(34): 12118-12131 [PMID: 25232247 DOI: 10.3748/wjg.v20.i34.12118] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 60] [Article Influence: 9.1] [Reference Citation Analysis]
158 Yamamoto KN, Nakamura A, Liu LL, Stein S, Tramontano AC, Kartoun U, Shimizu T, Inoue Y, Asakuma M, Haeno H, Kong CY, Uchiyama K, Gonen M, Hur C, Michor F. Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies. PLoS One 2019;14:e0215409. [PMID: 31026288 DOI: 10.1371/journal.pone.0215409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
159 Chandana S, Babiker HM, Mahadevan D. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC). Expert Opinion on Investigational Drugs 2018;28:161-77. [DOI: 10.1080/13543784.2019.1557145] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
160 Bauer TM, Dhir T, Strickland A, Thomsett H, Goetz AB, Cannaday S, Brody JR, Pishvaian MJ, Yeo CJ. Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure. J Pancreat Cancer 2018;4:81-7. [PMID: 30788462 DOI: 10.1089/pancan.2018.0015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
161 Lau D, Leach MR, La Marca F, Park P. Independent predictors of survival and the impact of repeat surgery in patients undergoing surgical treatment of spinal metastasis: Clinical article. SPI 2012;17:565-76. [DOI: 10.3171/2012.8.spine12449] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
162 Ow TJ, Sandulache VC, Skinner HD, Myers JN. Integration of cancer genomics with treatment selection: from the genome to predictive biomarkers. Cancer 2013;119:3914-28. [PMID: 24037788 DOI: 10.1002/cncr.28304] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
163 Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. The Lancet 2004;363:1049-57. [DOI: 10.1016/s0140-6736(04)15841-8] [Cited by in Crossref: 1360] [Cited by in F6Publishing: 672] [Article Influence: 75.6] [Reference Citation Analysis]
164 Mardis ER. Applying next-generation sequencing to pancreatic cancer treatment. Nat Rev Gastroenterol Hepatol 2012;9:477-86. [PMID: 22751458 DOI: 10.1038/nrgastro.2012.126] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
165 Pan H, Diao H, Zhong W, Wang T, Wen P, Wu C. A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis. Front Oncol 2021;11:656564. [PMID: 34055623 DOI: 10.3389/fonc.2021.656564] [Reference Citation Analysis]
166 Yu J, Blackford AL, Dal Molin M, Wolfgang CL, Goggins M. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut. 2015;Epub ahead of print. [PMID: 25636698 DOI: 10.1136/gutjnl-2014-308653] [Cited by in Crossref: 84] [Cited by in F6Publishing: 92] [Article Influence: 12.0] [Reference Citation Analysis]
167 Paliogiannis P, Cossu A, Tanda F, Palmieri G, Palomba G. KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma. Oncol Lett 2014;8:1422-6. [PMID: 25202344 DOI: 10.3892/ol.2014.2411] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
168 Notta F, Hahn SA, Real FX. A genetic roadmap of pancreatic cancer: still evolving. Gut. 2017;66:2170-2178. [PMID: 28993418 DOI: 10.1136/gutjnl-2016-313317] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
169 Ng CK, Cooke SL, Howe K, Newman S, Xian J, Temple J, Batty EM, Pole JC, Langdon SP, Edwards PA, Brenton JD. The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer. J Pathol 2012;226:703-12. [PMID: 22183581 DOI: 10.1002/path.3980] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
170 Oshima G, Stack ME, Wightman SC, Bryan D, Poli E, Xue L, Skowron KB, Uppal A, Pitroda SP, Huang X, Posner MC, Hellman S, Weichselbaum RR, Khodarev NN. Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones. J Vis Exp 2016. [PMID: 27929457 DOI: 10.3791/54657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
171 Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K. Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution. PLoS Genet 2016;12:e1005778. [PMID: 26890883 DOI: 10.1371/journal.pgen.1005778] [Cited by in Crossref: 97] [Cited by in F6Publishing: 80] [Article Influence: 16.2] [Reference Citation Analysis]
172 Sha Y, Sha Y, Ji Z, Ding L, Zhang Q, Ouyang H, Lin S, Wang X, Shao L, Shi C, Li P, Song Y. Comprehensive Genome Profiling of Single Sperm Cells by Multiple Annealing and Looping-Based Amplification Cycles and Next-Generation Sequencing from Carriers of Robertsonian Translocation. Ann Hum Genet 2017;81:91-7. [PMID: 28205220 DOI: 10.1111/ahg.12187] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
173 Morgan TK, Hardiman K, Corless CL, White SL, Bonnah R, Van de Vrugt H, Sheppard BC, Grompe M, Cosar EF, Streeter PR. Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia. Cancer Cytopathol 2013;121:37-46. [PMID: 22811080 DOI: 10.1002/cncy.21223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
174 Nguyen AV, Trompetto B, Tan XHM, Scott MB, Hu KH, Deeds E, Butte MJ, Chiou PY, Rowat AC. Differential Contributions of Actin and Myosin to the Physical Phenotypes and Invasion of Pancreatic Cancer Cells. Cell Mol Bioeng 2020;13:27-44. [PMID: 32030106 DOI: 10.1007/s12195-019-00603-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
175 De S, Ganesan S. Looking beyond drivers and passengers in cancer genome sequencing data. Ann Oncol 2017;28:938-45. [PMID: 27998972 DOI: 10.1093/annonc/mdw677] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
176 Dogra P, Ramírez JR, Peláez MJ, Wang Z, Cristini V, Parasher G, Rawat M. Mathematical Modeling to Address Challenges in Pancreatic Cancer. Curr Top Med Chem 2020;20:367-76. [PMID: 31893993 DOI: 10.2174/1568026620666200101095641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
177 Pishvaian MJ, Joseph Bender R, Matrisian LM, Rahib L, Hendifar A, Hoos WA, Mikhail S, Chung V, Picozzi V, Heartwell C. A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative. Oncotarget. 2016;8:83446-83456. [PMID: 29137355 DOI: 10.18632/oncotarget.13225] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
178 Roper N, Gao S, Maity TK, Banday AR, Zhang X, Venugopalan A, Cultraro CM, Patidar R, Sindiri S, Brown AL, Goncearenco A, Panchenko AR, Biswas R, Thomas A, Rajan A, Carter CA, Kleiner DE, Hewitt SM, Khan J, Prokunina-Olsson L, Guha U. APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors. Cell Rep 2019;26:2651-2666.e6. [PMID: 30840888 DOI: 10.1016/j.celrep.2019.02.028] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 19.5] [Reference Citation Analysis]
179 Casey L, Singh N. Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances. Histopathology 2020;76:37-51. [PMID: 31846521 DOI: 10.1111/his.13985] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
180 Mascariñas E, Eibl G, Grippo PJ. Evaluating dietary compounds in pancreatic cancer modeling systems. Methods Mol Biol 2013;980:225-48. [PMID: 23359157 DOI: 10.1007/978-1-62703-287-2_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
181 Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell. 2012;148:362-375. [PMID: 22265421 DOI: 10.1016/j.cell.2011.11.060.computational] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Mohammed A, Janakiram NB, Suen C, Stratton N, Lightfoot S, Singh A, Pathuri G, Ritchie R, Madka V, Rao CV. Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention. Mol Carcinog 2019;58:1908-18. [PMID: 31313401 DOI: 10.1002/mc.23084] [Reference Citation Analysis]
183 Lianos GD, Mangano A, Rausei S, Katsios C, Roukos DH. Tumor heterogeneity-based resistance guides personalized cancer medicine. Future Oncology 2014;10:1889-92. [DOI: 10.2217/fon.14.122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
184 Reimer T, Engel J, Schmidt M, Offersen BV, Smidt ML, Gentilini OD. Is Axillary Sentinel Lymph Node Biopsy Required in Patients Who Undergo Primary Breast Surgery? Breast Care (Basel) 2018;13:324-30. [PMID: 30498416 DOI: 10.1159/000491703] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
185 Ng CK, Pemberton HN, Reis-Filho JS. Breast cancer intratumor genetic heterogeneity: causes and implications. Expert Rev Anticancer Ther 2012;12:1021-32. [PMID: 23030222 DOI: 10.1586/era.12.85] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.7] [Reference Citation Analysis]
186 Cho W, Ziogas DE, Katsios C, Roukos DH. Emerging personalized oncology: sequencing and systems strategies. Future Oncol. 2012;8:637-641. [PMID: 22764759 DOI: 10.2217/fon.12.44] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
187 Li X, Meng D, Chen S, Luo H, Zhang Q, Jin W, Yan J. Single nucleus sequencing reveals spermatid chromosome fragmentation as a possible cause of maize haploid induction. Nat Commun 2017;8:991. [PMID: 29062086 DOI: 10.1038/s41467-017-00969-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 7.2] [Reference Citation Analysis]
188 Hsieh CC, Shyr YM, Liao WY, Chen TH, Wang SE, Lu PC, Lin PY, Chen YB, Mao WY, Han HY, Hsiao M, Yang WB, Li WS, Sher YP, Shen CN. Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis. Oncotarget 2017;8:7691-709. [PMID: 28032597 DOI: 10.18632/oncotarget.13845] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
189 Amato E, Mafficini A, Hirabayashi K, Lawlor RT, Fassan M, Vicentini C, Barbi S, Delfino P, Sikora K, Rusev B, Simbolo M, Esposito I, Antonello D, Pea A, Sereni E, Ballotta M, Maggino L, Marchegiani G, Ohike N, Wood LD, Salvia R, Klöppel G, Zamboni G, Scarpa A, Corbo V. Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas. J Pathol 2019;247:123-34. [PMID: 30306561 DOI: 10.1002/path.5180] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
190 Corbo V, Tortora G, Scarpa A. Molecular pathology of pancreatic cancer: from bench-to-bedside translation. Curr Drug Targets. 2012;13:744-752. [PMID: 22458520 DOI: 10.2174/138945012800564103] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
191 Hou Y, Song L, Zhu P, Zhang B, Tao Y, Xu X, Li F, Wu K, Liang J, Shao D. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell. 2012;148:873-885. [PMID: 22385957 DOI: 10.1016/j.cell.2012.02.028] [Cited by in Crossref: 399] [Cited by in F6Publishing: 346] [Article Influence: 39.9] [Reference Citation Analysis]
192 Stearns SC. Frontiers in Molecular Evolutionary Medicine. J Mol Evol 2020;88:3-11. [PMID: 30968167 DOI: 10.1007/s00239-019-09893-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
193 Srivastava S, Reid BJ, Ghosh S, Kramer BS. Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening. J Cell Physiol 2016;231:1870-5. [PMID: 26505642 DOI: 10.1002/jcp.25227] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
194 Reyngold M, Turcan S, Giri D, Kannan K, Walsh LA, Viale A, Drobnjak M, Vahdat LT, Lee W, Chan TA. Remodeling of the methylation landscape in breast cancer metastasis. PLoS One 2014;9:e103896. [PMID: 25083786 DOI: 10.1371/journal.pone.0103896] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
195 Lauth M, Toftgård R. Hedgehog signaling and pancreatic tumor development. Adv Cancer Res. 2011;110:1-17 [PMID: 21704226 DOI: 10.1016/B978-0-12-386469-7.00001-3]. [PMID: 21704226 DOI: 10.1016/B978-0-12-386469-7.00001-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
196 George B. Precision Medicine and Pancreatic Cancer. Surg Oncol Clin N Am 2021;30:693-708. [PMID: 34511190 DOI: 10.1016/j.soc.2021.06.008] [Reference Citation Analysis]
197 Connor AA, Denroche RE, Jang GH, Lemire M, Zhang A, Chan-Seng-Yue M, Wilson G, Grant RC, Merico D, Lungu I, Bartlett JMS, Chadwick D, Liang SB, Eagles J, Mbabaali F, Miller JK, Krzyzanowski P, Armstrong H, Luo X, Jorgensen LGT, Romero JM, Bavi P, Fischer SE, Serra S, Hafezi-Bakhtiari S, Caglar D, Roehrl MHA, Cleary S, Hollingsworth MA, Petersen GM, Thayer S, Law CHL, Nanji S, Golan T, Smith AL, Borgida A, Dodd A, Hedley D, Wouters BG, O'Kane GM, Wilson JM, Zogopoulos G, Notta F, Knox JJ, Gallinger S. Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. Cancer Cell 2019;35:267-282.e7. [PMID: 30686769 DOI: 10.1016/j.ccell.2018.12.010] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 19.3] [Reference Citation Analysis]
198 Oldfield LE, Connor AA, Gallinger S. Molecular Events in the Natural History of Pancreatic Cancer. Trends Cancer 2017;3:336-46. [PMID: 28718411 DOI: 10.1016/j.trecan.2017.04.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
199 Wood LD, Yurgelun MB, Goggins MG. Genetics of Familial and Sporadic Pancreatic Cancer. Gastroenterology 2019;156:2041-55. [PMID: 30660730 DOI: 10.1053/j.gastro.2018.12.039] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 8.7] [Reference Citation Analysis]
200 Glumac PM, LeBeau AM. The role of CD133 in cancer: a concise review. Clin Transl Med. 2018;7:18. [PMID: 29984391 DOI: 10.1186/s40169-018-0198-1] [Cited by in Crossref: 121] [Cited by in F6Publishing: 113] [Article Influence: 30.3] [Reference Citation Analysis]
201 Gao Q, Wang ZC, Duan M, Lin YH, Zhou XY, Worthley DL, Wang XY, Niu G, Xia Y, Deng M, Liu LZ, Shi JY, Yang LX, Zhang S, Ding ZB, Zhou J, Liang CM, Cao Y, Xiong L, Xi R, Shi YY, Fan J. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents. Gastroenterology. 2017;152:232-242.e4. [PMID: 27639803 DOI: 10.1053/j.gastro.2016.09.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 12.0] [Reference Citation Analysis]
202 Goel G, Sun W. Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future. J Hematol Oncol. 2015;8:44. [PMID: 25935754 DOI: 10.1186/s13045-015-0141-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
203 Joliat GR, Petermann D, Demartines N, Schäfer M. External assessment of the Early Mortality Risk Score in patients with adenocarcinoma undergoing pancreaticoduodenectomy. HPB (Oxford) 2015;17:605-10. [PMID: 25906918 DOI: 10.1111/hpb.12422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
204 Wheeler DA, Wang L. From human genome to cancer genome: the first decade. Genome Res. 2013;23:1054-1062. [PMID: 23817046 DOI: 10.1101/gr.157602.113] [Cited by in Crossref: 90] [Cited by in F6Publishing: 76] [Article Influence: 10.0] [Reference Citation Analysis]
205 Asai A, Konno M, Ozaki M, Kawamoto K, Chijimatsu R, Kondo N, Hirotsu T, Ishii H. Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer. Oncotarget 2021;12:1687-96. [PMID: 34434497 DOI: 10.18632/oncotarget.28035] [Reference Citation Analysis]
206 Bria E, Pilotto S, Amato E, Fassan M, Novello S, Peretti U, Vavalà T, Kinspergher S, Righi L, Santo A, Brunelli M, Corbo V, Giglioli E, Sperduti I, Milella M, Chilosi M, Scarpa A, Tortora G. Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma. Oncotarget 2015;6:12783-95. [PMID: 25904052 DOI: 10.18632/oncotarget.3727] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
207 Miller CA, White BS, Dees ND, Griffith M, Welch JS, Griffith OL, Vij R, Tomasson MH, Graubert TA, Walter MJ, Ellis MJ, Schierding W, DiPersio JF, Ley TJ, Mardis ER, Wilson RK, Ding L. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput Biol 2014;10:e1003665. [PMID: 25102416 DOI: 10.1371/journal.pcbi.1003665] [Cited by in Crossref: 273] [Cited by in F6Publishing: 227] [Article Influence: 34.1] [Reference Citation Analysis]
208 Reiter JG, Bozic I, Allen B, Chatterjee K, Nowak MA. The effect of one additional driver mutation on tumor progression. Evol Appl 2013;6:34-45. [PMID: 23396615 DOI: 10.1111/eva.12020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
209 Maddipati R, Stanger BZ. Pancreatic Cancer Metastases Harbor Evidence of Polyclonality. Cancer Discov 2015;5:1086-97. [PMID: 26209539 DOI: 10.1158/2159-8290.CD-15-0120] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 20.4] [Reference Citation Analysis]
210 Lin L, Lin DC. Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2019;11:E1156. [PMID: 31409002 DOI: 10.3390/cancers11081156] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
211 Wood LD, Hruban RH. Genomic landscapes of pancreatic neoplasia. J Pathol Transl Med 2015;49:13-22. [PMID: 25812653 DOI: 10.4132/jptm.2014.12.26] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
212 Poste G. Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards. Trends Mol Med 2012;18:717-22. [PMID: 23122852 DOI: 10.1016/j.molmed.2012.09.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
213 Eskander MF, Bliss LA, Tseng JF. Pancreatic adenocarcinoma. Current Problems in Surgery 2016;53:107-54. [DOI: 10.1067/j.cpsurg.2016.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
214 Lambert AW, Pattabiraman DR, Weinberg RA. Emerging Biological Principles of Metastasis. Cell. 2017;168:670-691. [PMID: 28187288 DOI: 10.1016/j.cell.2016.11.037] [Cited by in Crossref: 1131] [Cited by in F6Publishing: 1055] [Article Influence: 226.2] [Reference Citation Analysis]
215 Vassaux G, Angelova A, Baril P, Midoux P, Rommelaere J, Cordelier P. The Promise of Gene Therapy for Pancreatic Cancer. Hum Gene Ther 2016;27:127-33. [PMID: 26603492 DOI: 10.1089/hum.2015.141] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
216 Rambow F, Marine JC, Goding CR. Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities. Genes Dev 2019;33:1295-318. [PMID: 31575676 DOI: 10.1101/gad.329771.119] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 22.7] [Reference Citation Analysis]
217 Oskarsson T, Batlle E, Massagué J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014;14:306-321. [PMID: 24607405 DOI: 10.1016/j.stem.2014.02.002] [Cited by in Crossref: 408] [Cited by in F6Publishing: 370] [Article Influence: 51.0] [Reference Citation Analysis]
218 Lee JJ, Huang J, England CG, McNally LR, Frieboes HB. Predictive modeling of in vivo response to gemcitabine in pancreatic cancer. PLoS Comput Biol 2013;9:e1003231. [PMID: 24068909 DOI: 10.1371/journal.pcbi.1003231] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
219 Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, Neale RE, Tempero M, Tuveson DA, Hruban RH, Neoptolemos JP. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022. [PMID: 27158978 DOI: 10.1038/nrdp.2016.22] [Cited by in Crossref: 657] [Cited by in F6Publishing: 617] [Article Influence: 109.5] [Reference Citation Analysis]
220 Brar G, Blais EM, Joseph Bender R, Brody JR, Sohal D, Madhavan S, Picozzi VJ, Hendifar AE, Chung VM, Halverson D, Mikhail S, Matrisian LM, Rahib L, Petricoin E, Pishvaian MJ. Multi-omic molecular comparison of primary versus metastatic pancreatic tumours. Br J Cancer 2019;121:264-70. [PMID: 31292535 DOI: 10.1038/s41416-019-0507-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
221 Birnbaum DJ, Adélaïde J, Mamessier E, Finetti P, Lagarde A, Monges G, Viret F, Gonçalvès A, Turrini O, Delpero JR. Genome profiling of pancreatic adenocarcinoma. Genes Chromosomes Cancer. 2011;50:456-465. [PMID: 21412932 DOI: 10.1002/gcc.20870] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 7.9] [Reference Citation Analysis]
222 Sato F, Saji S, Toi M. Genomic tumor evolution of breast cancer. Breast Cancer 2016;23:4-11. [DOI: 10.1007/s12282-015-0617-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
223 Malek JA, Martinez A, Mery E, Ferron G, Huang R, Raynaud C, Jouve E, Thiery JP, Querleu D, Rafii A. Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis. J Transl Med 2012;10:121. [PMID: 22687175 DOI: 10.1186/1479-5876-10-121] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
224 Lonardo E, Cioffi M, Sancho P, Crusz S, Heeschen C. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies. J Vis Exp 2015;:e52801. [PMID: 26132091 DOI: 10.3791/52801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
225 Beckman R. Genetic Instability of Cancer. In: Madhusudan S, Wilson D, editors. DNA Repair and Cancer. CRC Press; 2013. pp. 63-91. [DOI: 10.1201/b14587-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
226 Spiliotis J, Halkia E, Roukos DH. Ovarian cancer screening and peritoneal carcinomatosis: standards, ‘omics’ and miRNAs for personalized management. Expert Review of Molecular Diagnostics 2014;11:465-7. [DOI: 10.1586/erm.11.29] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
227 Imai K, Karasaki H, Ono Y, Sasajima J, Chiba S, Funakoshi H, Muraki M, Hanaoka H, Furukawa T, Furukawa H, Kono T, Nagashima K, Mizukami Y. Metachronous pancreatic cancer originating from disseminated founder pancreatic intraductal neoplasias (PanINs). J Pathol Clin Res 2015;1:76-82. [PMID: 27499895 DOI: 10.1002/cjp2.8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
228 Mukherjee S, Rodriguez-canales J, Hanson J, Emmert-buck MR, Tangrea MA, Prieto DA, Blonder J, Johann DJ. Proteomic Analysis of Frozen Tissue Samples Using Laser Capture Microdissection. In: Zhou M, Veenstra T, editors. Proteomics for Biomarker Discovery. Totowa: Humana Press; 2013. pp. 71-83. [DOI: 10.1007/978-1-62703-360-2_6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
229 Zahn H, Steif A, Laks E, Eirew P, VanInsberghe M, Shah SP, Aparicio S, Hansen CL. Scalable whole-genome single-cell library preparation without preamplification. Nat Methods 2017;14:167-73. [PMID: 28068316 DOI: 10.1038/nmeth.4140] [Cited by in Crossref: 96] [Cited by in F6Publishing: 71] [Article Influence: 19.2] [Reference Citation Analysis]
230 Bergamo A, Dyson PJ, Sava G. The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions. Coordination Chemistry Reviews 2018;360:17-33. [DOI: 10.1016/j.ccr.2018.01.009] [Cited by in Crossref: 61] [Cited by in F6Publishing: 40] [Article Influence: 15.3] [Reference Citation Analysis]
231 Rosenbloom DIS, Camara PG, Chu T, Rabadan R. Evolutionary scalpels for dissecting tumor ecosystems. Biochim Biophys Acta Rev Cancer 2017;1867:69-83. [PMID: 27923679 DOI: 10.1016/j.bbcan.2016.11.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
232 Lovecek M, Skalicky P, Chudacek J, Szkorupa M, Svebisova H, Lemstrova R, Ehrmann J, Melichar B, Yogeswara T, Klos D, Vrba R, Havlik R, Mohelnikova-Duchonova B. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature. World J Gastroenterol 2017; 23(35): 6420-6428 [PMID: 29085191 DOI: 10.3748/wjg.v23.i35.6420] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
233 Yan J, Huang Q. Genomics screens for metastasis genes. Cancer Metastasis Rev 2012;31:419-28. [PMID: 22684367 DOI: 10.1007/s10555-012-9362-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
234 Kakiuchi N, Ogawa S. Clonal expansion in non-cancer tissues. Nat Rev Cancer 2021;21:239-56. [DOI: 10.1038/s41568-021-00335-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
235 Vieira de Castro J, Gonçalves CS, Hormigo A, Costa BM. Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting. Int J Mol Sci 2020;21:E5278. [PMID: 32722427 DOI: 10.3390/ijms21155278] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
236 Lee SH, Yoo J, Song YS, Lim CH, Kim TM. Mutation Analysis of Colorectal and Gastric Carcinomas Originating from Adenomas: Insights into Genomic Evolution Associated with Malignant Progression. Cancers (Basel) 2020;12:E325. [PMID: 32023847 DOI: 10.3390/cancers12020325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
237 Pezzilli R, Fabbri D, Imbrogno A. Pancreatic ductal adenocarcinoma screening: New perspectives. World J Gastroenterol 2012; 18(36): 4973-4977 [PMID: 23049204 DOI: 10.3748/wjg.v18.i36.4973] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
238 Hwang IC, Chang J, Park SM. Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study. PLoS One 2018;13:e0203918. [PMID: 30208110 DOI: 10.1371/journal.pone.0203918] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
239 Yamao K, Tsurusaki M, Takashima K, Tanaka H, Yoshida A, Okamoto A, Yamazaki T, Omoto S, Kamata K, Minaga K, Takenaka M, Chikugo T, Chiba Y, Watanabe T, Kudo M. Analysis of Progression Time in Pancreatic Cancer including Carcinoma In Situ Based on Magnetic Resonance Cholangiopancreatography Findings. Diagnostics (Basel) 2021;11:1858. [PMID: 34679556 DOI: 10.3390/diagnostics11101858] [Reference Citation Analysis]
240 Mota A, S Oltra S, Moreno-Bueno G. Insight updating of the molecular hallmarks in ovarian carcinoma. EJC Suppl 2020;15:16-26. [PMID: 33240439 DOI: 10.1016/j.ejcsup.2019.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
241 Dzobo K, Rowe A, Senthebane DA, AlMazyadi MAM, Patten V, Parker MI. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling. OMICS 2018;22:733-48. [PMID: 30571609 DOI: 10.1089/omi.2018.0172] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
242 Otake S, Goto T. Stereotactic Radiotherapy for Oligometastasis. Cancers (Basel) 2019;11:E133. [PMID: 30678111 DOI: 10.3390/cancers11020133] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
243 O'Reilly EM. Adjuvant therapy for pancreas adenocarcinoma: where are we going? Expert Rev Anticancer Ther 2011;11:173-7. [PMID: 21342036 DOI: 10.1586/era.10.232] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
244 Zhou M, Hall L, Goldgof D, Russo R, Balagurunathan Y, Gillies R, Gatenby R. Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results. Transl Oncol 2014;7:5-13. [PMID: 24772202 DOI: 10.1593/tlo.13730] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
245 Zhang G, Vemulapalli TH, Yang JY. Phylooncogenomics: Examining the cancer genome in the context of vertebrate evolution. Appl Transl Genom 2013;2:48-54. [PMID: 27896055 DOI: 10.1016/j.atg.2013.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
246 Venook AP, Stagg RJ, Lewis BJ. Regional chemotherapy for colorectal cancer metastatic to the liver. Oncology (Williston Park) 1988;2:19-26. [PMID: 3079322 [PMID: 3079322 DOI: 10.1158/1078-0432.ccr-10-3074] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
247 Casals E, Gusta MF, Cobaleda-Siles M, Garcia-Sanz A, Puntes VF. Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles. Cancer Nanotechnol 2017;8:7. [PMID: 29104700 DOI: 10.1186/s12645-017-0030-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
248 Ikemoto J, Hanada K, Minami T, Okazaki A, Abe T, Amano H, Yonehara S. Prospective Follow-up Study of the Recurrence of Pancreatic Cancer Diagnosed at an Early Stage: The Value of Endoscopic Ultrasonography for Early Diagnosis of Recurrence in the Remnant Pancreas. Pancreas 2018;47:482-8. [DOI: 10.1097/mpa.0000000000001021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
249 Glassman DC, Palmaira RL, Covington CM, Desai AM, Ku GY, Li J, Harding JJ, Varghese AM, O'Reilly EM, Yu KH. Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience. BMC Cancer 2018;18:693. [PMID: 29945562 DOI: 10.1186/s12885-018-4605-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
250 Klebanoff CA, Rosenberg SA, Restifo NP. Prospects for gene-engineered T cell immunotherapy for solid cancers. Nat Med. 2016;22:26-36. [PMID: 26735408 DOI: 10.1038/nm.4015] [Cited by in Crossref: 216] [Cited by in F6Publishing: 206] [Article Influence: 36.0] [Reference Citation Analysis]
251 Bustelo XR. Intratumoral stages of metastatic cells: A synthesis of ontogeny, Rho/Rac GTPases, epithelial-mesenchymal transitions, and more. Bioessays 2012;34:748-59. [DOI: 10.1002/bies.201200041] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
252 Bernard V, Fleming J, Maitra A. Molecular and Genetic Basis of Pancreatic Carcinogenesis. Surgical Oncology Clinics of North America 2016;25:227-38. [DOI: 10.1016/j.soc.2015.11.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
253 Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, Muthuswamy L, Krasnitz A, McCombie WR, Hicks J, Wigler M. Tumour evolution inferred by single-cell sequencing. Nature 2011;472:90-4. [PMID: 21399628 DOI: 10.1038/nature09807] [Cited by in Crossref: 1674] [Cited by in F6Publishing: 1457] [Article Influence: 152.2] [Reference Citation Analysis]
254 Liu T, Liu Y, Xie L, He X, Bai J. Progress in the pathogenesis of pterygium. Curr Eye Res 2013;38:1191-7. [PMID: 24047084 DOI: 10.3109/02713683.2013.823212] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
255 Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15:81-94. [PMID: 29115304 DOI: 10.1038/nrclinonc.2017.166] [Cited by in Crossref: 831] [Cited by in F6Publishing: 737] [Article Influence: 166.2] [Reference Citation Analysis]
256 Guo T, Li L, Zhong Q, Rupp NJ, Charmpi K, Wong CE, Wagner U, Rueschoff JH, Jochum W, Fankhauser CD, Saba K, Poyet C, Wild PJ, Aebersold R, Beyer A. Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers. Life Sci Alliance 2018;1:e201800042. [PMID: 30090875 DOI: 10.26508/lsa.201800042] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
257 Vennin C, Murphy KJ, Morton JP, Cox TR, Pajic M, Timpson P. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer. Gastroenterology 2018;154:820-38. [PMID: 29287624 DOI: 10.1053/j.gastro.2017.11.280] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 19.6] [Reference Citation Analysis]
258 Makawita S, Smith C, Batruch I, Zheng Y, Rückert F, Grützmann R, Pilarsky C, Gallinger S, Diamandis EP. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol Cell Proteomics 2011;10:M111.008599. [PMID: 21653254 DOI: 10.1074/mcp.M111.008599] [Cited by in Crossref: 78] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
259 Mikhailova V, Gulaia V, Tiasto V, Rybtsov S, Yatsunskaya M, Kagansky A. Towards an advanced cell-based in vitro glioma model system. AIMS Genet 2018;5:91-112. [PMID: 31435515 DOI: 10.3934/genet.2018.2.91] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
260 Bednar F, Simeone DM. Pancreatic cancer stem cell biology and its therapeutic implications. J Gastroenterol. 2011;46:1345-1352. [PMID: 22048257 DOI: 10.1007/s00535-011-0494-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
261 Pereira SP, Oldfield L, Ney A, Hart PA, Keane MG, Pandol SJ, Li D, Greenhalf W, Jeon CY, Koay EJ, Almario CV, Halloran C, Lennon AM, Costello E. Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol. 2020;5:698-710. [PMID: 32135127 DOI: 10.1016/s2468-1253(19)30416-9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 22.0] [Reference Citation Analysis]
262 Karn T. High-throughput gene expression and mutation profiling: current methods and future perspectives. Breast Care (Basel) 2013;8:401-6. [PMID: 24550747 DOI: 10.1159/000357461] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
263 Ma B, Wells A, Clark AM. The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment. Semin Cancer Biol 2020;60:138-47. [PMID: 31376430 DOI: 10.1016/j.semcancer.2019.07.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
264 Roukos DH. Spatiotemporal diversification of intrapatient genomic clones and early drug development concepts realize the roadmap of precision cancer medicine. Drug Discov Today 2017;22:1148-64. [PMID: 28400153 DOI: 10.1016/j.drudis.2017.03.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
265 Nguyen A, Yoshida M, Goodarzi H, Tavazoie SF. Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness. Nat Commun. 2016;7:11246. [PMID: 27138336 DOI: 10.1038/ncomms11246] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 8.7] [Reference Citation Analysis]
266 Durmus N, Shao Y, Arslan AA, Zhang Y, Pehlivan S, Fernandez-Beros ME, Umana L, Corona R, Smyth-Giambanco S, Abbott SA, Reibman J. Characteristics of Cancer Patients in the World Trade Center Environmental Health Center. Int J Environ Res Public Health 2020;17:E7190. [PMID: 33019547 DOI: 10.3390/ijerph17197190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
267 de Heer J, Göke B. Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas? Expert Opinion on Drug Safety 2014;13:1469-81. [DOI: 10.1517/14740338.2014.955013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
268 Zhou B, Irwanto A, Guo Y, Bei J, Wu Q, Chen G, Zhang T, Lei J, Feng Q, Chen L, Liu J, Zhao Y. Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma. Cancer Biology & Therapy 2014;13:871-9. [DOI: 10.4161/cbt.20839] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
269 Ren Z, Jiang J, Xie H, Li A, Lu H, Xu S, Zhou L, Zhang H, Cui G, Chen X, Liu Y, Wu L, Qin N, Sun R, Wang W, Li L, Zheng S. Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China. Oncotarget. 2017;8:95176-95191. [PMID: 29221120 DOI: 10.18632/oncotarget.18820] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 11.4] [Reference Citation Analysis]
270 Langdon CG, Platt JT, Means RE, Iyidogan P, Mamillapalli R, Klein M, Held MA, Lee JW, Koo JS, Hatzis C, Hochster HS, Stern DF. Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor. Mol Cancer Ther 2017;16:1041-53. [PMID: 28292938 DOI: 10.1158/1535-7163.MCT-16-0794] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
271 Li T, Zheng Y, Sun H, Zhuang R, Liu J, Liu T, Cai W. K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis. Med Oncol 2016;33:61. [PMID: 27225938 DOI: 10.1007/s12032-016-0777-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
272 Ellsworth KA, Eckloff BW, Li L, Moon I, Fridley BL, Jenkins GD, Carlson E, Brisbin A, Abo R, Bamlet W, Petersen G, Wieben ED, Wang L. Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. PLoS One 2013;8:e70216. [PMID: 23936393 DOI: 10.1371/journal.pone.0070216] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
273 Yuan C, Bao Y, Wu C, Kraft P, Ogino S, Ng K, Qian ZR, Rubinson DA, Stampfer MJ, Giovannucci EL, Wolpin BM. Prediagnostic body mass index and pancreatic cancer survival. J Clin Oncol. 2013;31:4229-4234. [PMID: 24145341 DOI: 10.1200/jco.2013.51.7532] [Cited by in Crossref: 78] [Cited by in F6Publishing: 44] [Article Influence: 8.7] [Reference Citation Analysis]
274 Storz P, Crawford HC. Carcinogenesis of Pancreatic Ductal Adenocarcinoma. Gastroenterology 2020;158:2072-81. [PMID: 32199881 DOI: 10.1053/j.gastro.2020.02.059] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
275 Saunus JM, Momeny M, Simpson PT, Lakhani SR, Da Silva L. Molecular aspects of breast cancer metastasis to the brain. Genet Res Int 2011;2011:219189. [PMID: 22567347 DOI: 10.4061/2011/219189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
276 Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674. [PMID: 21376230 DOI: 10.1016/j.cell.2011.02.013] [Cited by in Crossref: 33789] [Cited by in F6Publishing: 31247] [Article Influence: 3071.7] [Reference Citation Analysis]
277 Gašić U, Ćirić I, Pejčić T, Radenković D, Djordjević V, Radulović S, Tešić Ž. Polyphenols as Possible Agents for Pancreatic Diseases. Antioxidants (Basel) 2020;9:E547. [PMID: 32585831 DOI: 10.3390/antiox9060547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
278 Barteneva NS, Ketman K, Fasler-Kan E, Potashnikova D, Vorobjev IA. Cell sorting in cancer research--diminishing degree of cell heterogeneity. Biochim Biophys Acta 2013;1836:105-22. [PMID: 23481260 DOI: 10.1016/j.bbcan.2013.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
279 Ilmer M, Schiergens TS, Renz BW, Schneider C, Sargut M, Waligora R, Weniger M, Hartwig W, Ceyhan GO, Friess H, Werner J, D'Haese JG. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection. Surg Oncol 2019;31:16-21. [PMID: 31473583 DOI: 10.1016/j.suronc.2019.08.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
280 Iacobuzio-Donahue CA, Velculescu VE, Wolfgang CL, Hruban RH. Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing. Clin Cancer Res. 2012;18:4257-4265. [PMID: 22896692 DOI: 10.1158/1078-0432.ccr-12-0315] [Cited by in Crossref: 85] [Cited by in F6Publishing: 53] [Article Influence: 9.4] [Reference Citation Analysis]
281 Erkan M, Kurtoglu M, Kleeff J. The role of hypoxia in pancreatic cancer: a potential therapeutic target? Expert Rev Gastroenterol Hepatol 2016;10:301-16. [PMID: 26560854 DOI: 10.1586/17474124.2016.1117386] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 9.4] [Reference Citation Analysis]
282 Roy N, Takeuchi KK, Ruggeri JM, Bailey P, Chang D, Li J, Leonhardt L, Puri S, Hoffman MT, Gao S, Halbrook CJ, Song Y, Ljungman M, Malik S, Wright CV, Dawson DW, Biankin AV, Hebrok M, Crawford HC. PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance. Genes Dev. 2016;30:2669-2683. [PMID: 28087712 DOI: 10.1101/gad.291021.116] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 11.4] [Reference Citation Analysis]
283 Hadden M, Mittal A, Samra J, Zreiqat H, Sahni S, Ramaswamy Y. Mechanically stressed cancer microenvironment: Role in pancreatic cancer progression.BiochimBiophysActa Rev Cancer. 2020;1874:188418. [PMID: 32827581 DOI: 10.1016/j.bbcan.2020.188418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
284 Moriarity BS, Largaespada DA. Sleeping Beauty transposon insertional mutagenesis based mouse models for cancer gene discovery. Curr Opin Genet Dev 2015;30:66-72. [PMID: 26051241 DOI: 10.1016/j.gde.2015.04.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
285 Lloyd MC, Cunningham JJ, Bui MM, Gillies RJ, Brown JS, Gatenby RA. Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces. Cancer Res 2016;76:3136-44. [PMID: 27009166 DOI: 10.1158/0008-5472.CAN-15-2962] [Cited by in Crossref: 146] [Cited by in F6Publishing: 95] [Article Influence: 24.3] [Reference Citation Analysis]
286 Archibugi L, Arcidiacono PG, Capurso G. Statin use is associated to a reduced risk of pancreatic cancer: A meta-analysis. Digestive and Liver Disease 2019;51:28-37. [DOI: 10.1016/j.dld.2018.09.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
287 Nickel GC, Barnholtz-Sloan J, Gould MP, McMahon S, Cohen A, Adams MD, Guda K, Cohen M, Sloan AE, LaFramboise T. Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence. PLoS One 2012;7:e35262. [PMID: 22536362 DOI: 10.1371/journal.pone.0035262] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
288 Martins-Filho SN, Alves VAF, Wakamatsu A, Maeda M, Craig AJ, Assato AK, Villacorta-Martin C, D'Avola D, Labgaa I, Carrilho FJ, Thung SN, Villanueva A. A phenotypical map of disseminated hepatocellular carcinoma suggests clonal constraints in metastatic sites. Histopathology. 2019;74:718-730. [PMID: 30636011 DOI: 10.1111/his.13809] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
289 Pai M, Spalding D. Pancreatic cancer. Medicine 2015;43:329-33. [DOI: 10.1016/j.mpmed.2015.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
290 . UEG Week 2019 Oral Presentations. United European Gastroenterol J 2019;7:10-188. [PMID: 32213000 DOI: 10.1177/2050640619854670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
291 Orlando PA, Gatenby RA, Brown JS. Tumor evolution in space: the effects of competition colonization tradeoffs on tumor invasion dynamics. Front Oncol 2013;3:45. [PMID: 23508890 DOI: 10.3389/fonc.2013.00045] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
292 Kawamata M, Katsuda T, Yamada Y, Ochiya T. In vitro reconstitution of breast cancer heterogeneity with multipotent cancer stem cells using small molecules. Biochemical and Biophysical Research Communications 2017;482:750-7. [DOI: 10.1016/j.bbrc.2016.11.106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
293 Ogawa H, Nagano H, Konno M, Eguchi H, Koseki J, Kawamoto K, Nishida N, Colvin H, Tomokuni A, Tomimaru Y. The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer. Mol Clin Oncol. 2015;3:563-571. [PMID: 26137268 DOI: 10.3892/mco.2015.490] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
294 Sleightholm RL, Neilsen BK, Li J, Steele MM, Singh RK, Hollingsworth MA, Oupicky D. Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy. Pharmacol Ther. 2017;179:158-170. [PMID: 28549596 DOI: 10.1016/j.pharmthera.2017.05.012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
295 Reddy KB. Stem Cells: Current Status and Therapeutic Implications. Genes (Basel) 2020;11:E1372. [PMID: 33233552 DOI: 10.3390/genes11111372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
296 Brannon AR, Vakiani E, Sylvester BE, Scott SN, McDermott G, Shah RH, Kania K, Viale A, Oschwald DM, Vacic V. Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol. 2014;15:454. [PMID: 25164765 DOI: 10.1186/s13059-014-0454-7] [Cited by in Crossref: 207] [Cited by in F6Publishing: 196] [Article Influence: 25.9] [Reference Citation Analysis]
297 Jürgensmeier JM, Eder JP, Herbst RS. New strategies in personalized medicine for solid tumors: molecular markers and clinical trial designs. Clin Cancer Res 2014;20:4425-35. [PMID: 25183480 DOI: 10.1158/1078-0432.CCR-13-0753] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
298 Ma J, Li J, Yao X, Lin S, Gu Y, Xu J, Deng Z, Ma W, Zhang H. FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide. Oncol Rep 2017;37:1935-42. [PMID: 28260065 DOI: 10.3892/or.2017.5483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
299 Siegmund KD, Marjoram P, Tavaré S, Shibata D. High DNA methylation pattern intratumoral diversity implies weak selection in many human colorectal cancers. PLoS One 2011;6:e21657. [PMID: 21738754 DOI: 10.1371/journal.pone.0021657] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
300 Griewank KG, Murali R. Pathology and genetics of uveal melanoma. Pathology 2013;45:18-27. [DOI: 10.1097/pat.0b013e32835c6505] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
301 Sun S, Klebaner F, Tian T. A new model of time scheme for progression of colorectal cancer. BMC Syst Biol 2014;8 Suppl 3:S2. [PMID: 25350788 DOI: 10.1186/1752-0509-8-S3-S2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
302 Gui P, Bivona TG. Evolution of metastasis: new tools and insights. Trends Cancer 2021:S2405-8033(21)00228-4. [PMID: 34872888 DOI: 10.1016/j.trecan.2021.11.002] [Reference Citation Analysis]
303 Liang C, Qin Y, Zhang B, Ji S, Shi S, Xu W, Liu J, Xiang J, Liang D, Hu Q, Ni Q, Xu J, Yu X. Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma. Biochim Biophys Acta. 2016;1866:177-188. [PMID: 27600832 DOI: 10.1016/j.bbcan.2016.09.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
304 Naxerova K, Reiter JG, Brachtel E, Lennerz JK, van de Wetering M, Rowan A, Cai T, Clevers H, Swanton C, Nowak MA. Origins of lymphatic and distant metastases in human colorectal cancer. Science. 2017;357:55-60. [PMID: 28684519 DOI: 10.1126/science.aai8515] [Cited by in Crossref: 200] [Cited by in F6Publishing: 181] [Article Influence: 50.0] [Reference Citation Analysis]
305 Nagai K, Mizukami Y, Omori Y, Kin T, Yane K, Takahashi K, Ono Y, Sugitani A, Karasaki H, Shinohara T, Furukawa T, Hayashi T, Okumura T, Maguchi H, Katanuma A. Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection. Mod Pathol 2020;33:971-80. [PMID: 31723240 DOI: 10.1038/s41379-019-0405-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
306 Timmer FEF, Geboers B, Nieuwenhuizen S, Schouten EAC, Dijkstra M, de Vries JJJ, van den Tol MP, Meijerink MR, Scheffer HJ. Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review. Cancers (Basel) 2021;13:1608. [PMID: 33807220 DOI: 10.3390/cancers13071608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
307 Regel I, Hausmann S, Benitz S, Esposito I, Kleeff J. Pathobiology of pancreatic cancer: implications on therapy. Expert Rev Anticancer Ther 2016;16:219-27. [PMID: 26652651 DOI: 10.1586/14737140.2016.1129276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
308 Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R, Wilson S, Moore M, Narod S, Jhaveri K, Haider MA, Gallinger S. Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. J Gastrointest Surg. 2012;16:771-783. [PMID: 22127781 DOI: 10.1007/s11605-011-1781-6] [Cited by in Crossref: 91] [Cited by in F6Publishing: 89] [Article Influence: 8.3] [Reference Citation Analysis]
309 He J, Cameron JL, Ahuja N, Makary MA, Hirose K, Choti MA, Schulick RD, Hruban RH, Pawlik TM, Wolfgang CL. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg. 2013;216:657-665; discussion 665-667. [PMID: 23395158 DOI: 10.1016/j.jamcollsurg.2012.12.026] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 10.2] [Reference Citation Analysis]
310 Makawita S, Dimitromanolakis A, Soosaipillai A, Soleas I, Chan A, Gallinger S, Haun RS, Blasutig IM, Diamandis EP. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. BMC Cancer. 2013;13:404. [PMID: 24007603 DOI: 10.1186/1471-2407-13-404] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
311 Hamada S, Masamune A, Shimosegawa T. Alteration of pancreatic cancer cell functions by tumor-stromal cell interaction. Front Physiol. 2013;4:318. [PMID: 24198790 DOI: 10.3389/fphys.2013.00318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
312 Bersani F, Morena D, Picca F, Morotti A, Tabbò F, Bironzo P, Righi L, Taulli R. Future perspectives from lung cancer pre-clinical models: new treatments are coming? Transl Lung Cancer Res 2020;9:2629-44. [PMID: 33489823 DOI: 10.21037/tlcr-20-189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
313 Moschos SA. Genomic biomarkers for patient selection and stratification: the cancer paradigm. Bioanalysis 2012;4:2499-511. [DOI: 10.4155/bio.12.241] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
314 Iqbal W, Alkarim S, AlHejin A, Mukhtar H, Saini KS. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis. Oncotarget 2016;7:76337-53. [PMID: 27486983 DOI: 10.18632/oncotarget.10942] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
315 Bracci PM, Zhou M, Young S, Wiemels J. Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study. Cancer. 2012;118:5384-5394. [PMID: 22517435 DOI: 10.1002/cncr.27538] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
316 Husain K, Centeno BA, Coppola D, Trevino J, Sebti SM, Malafa MP. δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis. Oncotarget 2017;8:31554-67. [PMID: 28404939 DOI: 10.18632/oncotarget.15767] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
317 Kafita D, Nkhoma P, Zulu M, Sinkala M. Proteogenomic analysis of pancreatic cancer subtypes. PLoS One 2021;16:e0257084. [PMID: 34506537 DOI: 10.1371/journal.pone.0257084] [Reference Citation Analysis]
318 Cen P, Ni X, Yang J, Graham DY, Li M. Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochim Biophys Acta. 2012;1826:350-356. [PMID: 22683404 DOI: 10.1016/j.bbcan.2012.05.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
319 Nagai M, Sho M, Akahori T, Nakagawa K, Nakamura K. Application of liquid biopsy for surgical management of pancreatic cancer. Ann Gastroenterol Surg 2020;4:216-23. [PMID: 32490335 DOI: 10.1002/ags3.12317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
320 Das S, Batra SK. Pancreatic cancer metastasis: are we being pre-EMTed. Curr Pharm Des. 2015;21:1249-1255. [PMID: 25506899 DOI: 10.2174/1381612821666141211115234] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
321 Lackey L, Law EK, Brown WL, Harris RS. Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination. Cell Cycle 2013;12:762-72. [PMID: 23388464 DOI: 10.4161/cc.23713] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 9.4] [Reference Citation Analysis]
322 Rahul A, Robin F, Adarsh H. Spontaneous Rupture of Hepatic Metastasis from Pancreatic Adenocarcinoma. Case Rep Oncol Med 2016;2016:6968534. [PMID: 27597912 DOI: 10.1155/2016/6968534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
323 Sistigu A, Musella M, Galassi C, Vitale I, De Maria R. Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening. Front Immunol 2020;11:2166. [PMID: 33193295 DOI: 10.3389/fimmu.2020.02166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
324 Eser S, Messer M, Eser P, von Werder A, Seidler B, Bajbouj M, Vogelmann R, Meining A, von Burstin J, Algül H. In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging. Proc Natl Acad Sci USA. 2011;108:9945-9950. [PMID: 21628592 DOI: 10.1073/pnas.1100890108] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 5.0] [Reference Citation Analysis]
325 Einaga N, Yoshida A, Noda H, Suemitsu M, Nakayama Y, Sakurada A, Kawaji Y, Yamaguchi H, Sasaki Y, Tokino T, Esumi M. Assessment of the quality of DNA from various formalin-fixed paraffin-embedded (FFPE) tissues and the use of this DNA for next-generation sequencing (NGS) with no artifactual mutation. PLoS One 2017;12:e0176280. [PMID: 28498833 DOI: 10.1371/journal.pone.0176280] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
326 Liu Z, Dong S, Jia J, Zhang Z, Zhen Z. KIF3B Promotes the Proliferation of Pancreatic Cancer. Cancer Biotherapy and Radiopharmaceuticals 2019;34:355-61. [DOI: 10.1089/cbr.2018.2716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
327 Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2020;17:139-152. [PMID: 31792430 DOI: 10.1038/s41575-019-0229-4] [Cited by in Crossref: 104] [Cited by in F6Publishing: 115] [Article Influence: 34.7] [Reference Citation Analysis]
328 Rudrapatna VA, Cagan RL, Das TK. Drosophila cancer models. Dev Dyn 2012;241:107-18. [PMID: 22038952 DOI: 10.1002/dvdy.22771] [Cited by in Crossref: 86] [Cited by in F6Publishing: 72] [Article Influence: 7.8] [Reference Citation Analysis]
329 Ouyang L, Lee J, Park CK, Mao M, Shi Y, Gong Z, Zheng H, Li Y, Zhao Y, Wang G, Fu H, Kim J, Lim HY. Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas. BMC Med Genomics 2014;7:2. [PMID: 24405831 DOI: 10.1186/1755-8794-7-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
330 Gayral M, Lulka H, Hanoun N, Biollay C, Sèlves J, Vignolle-Vidoni A, Berthommé H, Trempat P, Epstein AL, Buscail L, Béjot JL, Cordelier P. Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors. Hum Gene Ther 2015;26:104-13. [PMID: 25423447 DOI: 10.1089/hum.2014.072] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
331 Soto AM, Sonnenschein C. The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory. Bioessays. 2011;33:332-340. [PMID: 21503935 DOI: 10.1002/bies.201100025] [Cited by in Crossref: 194] [Cited by in F6Publishing: 164] [Article Influence: 17.6] [Reference Citation Analysis]
332 Hameetman L, Commandeur S, Bavinck JN, Wisgerhof HC, de Gruijl FR, Willemze R, Mullenders L, Tensen CP, Vrieling H. Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients. BMC Cancer 2013;13:58. [PMID: 23379751 DOI: 10.1186/1471-2407-13-58] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
333 Li D, Mullinax JE, Aiken T, Xin H, Wiegand G, Anderson A, Thorgeirsson S, Avital I, Rudloff U. Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. BMC Cancer 2018;18:772. [PMID: 30064387 DOI: 10.1186/s12885-018-4690-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
334 Jensen GL, Tang C, Hess KR, Liao Z, Gomez DR. Patterns of metastatic progression after definitive radiation therapy for early-stage and locally advanced non-small cell lung cancer. Clin Exp Metastasis 2017;34:315-22. [PMID: 28744603 DOI: 10.1007/s10585-017-9850-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
335 Khodadoust MS, Alizadeh AA. Tumor antigen discovery through translation of the cancer genome. Immunol Res 2014;58:292-9. [PMID: 24718952 DOI: 10.1007/s12026-014-8505-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
336 Schmid KW. [Lymph node and distant metastases of thyroid gland cancer. Metastases in the thyroid glands]. Pathologe 2015;36 Suppl 2:171-5. [PMID: 26357953 DOI: 10.1007/s00292-015-0071-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
337 Lawson DA, Kessenbrock K, Davis RT, Pervolarakis N, Werb Z. Tumour heterogeneity and metastasis at single-cell resolution. Nat Cell Biol 2018;20:1349-60. [PMID: 30482943 DOI: 10.1038/s41556-018-0236-7] [Cited by in Crossref: 191] [Cited by in F6Publishing: 149] [Article Influence: 47.8] [Reference Citation Analysis]
338 Murtaugh LC. Pathogenesis of pancreatic cancer: lessons from animal models. Toxicol Pathol 2014;42:217-28. [PMID: 24178582 DOI: 10.1177/0192623313508250] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
339 Knudsen ES, O'Reilly EM, Brody JR, Witkiewicz AK. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine. Gastroenterology. 2016;150:48-63. [PMID: 26385075 DOI: 10.1053/j.gastro.2015.08.056] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 9.0] [Reference Citation Analysis]
340 Lee JH, Daugharthy ER, Scheiman J, Kalhor R, Ferrante TC, Terry R, Turczyk BM, Yang JL, Lee HS, Aach J, Zhang K, Church GM. Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues. Nat Protoc 2015;10:442-58. [PMID: 25675209 DOI: 10.1038/nprot.2014.191] [Cited by in Crossref: 236] [Cited by in F6Publishing: 220] [Article Influence: 33.7] [Reference Citation Analysis]
341 Perales-Patón J, Piñeiro-Yañez E, Tejero H, López-Casas PP, Hidalgo M, Gómez-López G, Al-Shahrour F. Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective. Public Health Genomics 2017;20:81-91. [PMID: 28858862 DOI: 10.1159/000479812] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
342 Yachida S, White CM, Naito Y, Zhong Y, Brosnan JA, Macgregor-Das AM, Morgan RA, Saunders T, Laheru DA, Herman JM. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin Cancer Res. 2012;18:6339-6347. [PMID: 22991414 DOI: 10.1158/1078-0432.ccr-12-1215] [Cited by in Crossref: 148] [Cited by in F6Publishing: 93] [Article Influence: 14.8] [Reference Citation Analysis]
343 Easwaran H, Tsai HC, Baylin SB. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell. 2014;54:716-727. [PMID: 24905005 DOI: 10.1016/j.molcel.2014.05.015] [Cited by in Crossref: 520] [Cited by in F6Publishing: 461] [Article Influence: 65.0] [Reference Citation Analysis]
344 Houg DS, Bijlsma MF. The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma. Mol Cancer. 2018;17:95. [PMID: 29903049 DOI: 10.1186/s12943-018-0842-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
345 Dienstmann R, Rodon J, Barretina J, Tabernero J. Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges. JCO 2013;31:1874-84. [DOI: 10.1200/jco.2012.45.2268] [Cited by in Crossref: 87] [Cited by in F6Publishing: 44] [Article Influence: 9.7] [Reference Citation Analysis]
346 Hong WS, Shpak M, Townsend JP. Inferring the Origin of Metastases from Cancer Phylogenies. Cancer Res 2015;75:4021-5. [PMID: 26260528 DOI: 10.1158/0008-5472.CAN-15-1889] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
347 Tamura K, Ohtsuka T, Date K, Fujimoto T, Matsunaga T, Kimura H, Watanabe Y, Miyazaki T, Ohuchida K, Takahata S, Ishigami K, Oda Y, Mizumoto K, Nakamura M, Tanaka M. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers. Pancreas 2016;45:826-35. [PMID: 26646266 DOI: 10.1097/MPA.0000000000000563] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
348 Cowan RW, Maitra A. Genetic progression of pancreatic cancer. Cancer J 2014;20:80-4. [PMID: 24445769 DOI: 10.1097/PPO.0000000000000011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
349 Ding Y, Mullapudi B, Torres C, Mascariñas E, Mancinelli G, Diaz AM, McKinney R, Barron M, Schultz M, Heiferman M, Wojtanek M, Adrian K, DeCant B, Rao S, Ouellette M, Tsao MS, Bentrem DJ, Grippo PJ. Omega-3 Fatty Acids Prevent Early Pancreatic Carcinogenesis via Repression of the AKT Pathway. Nutrients 2018;10:E1289. [PMID: 30213082 DOI: 10.3390/nu10091289] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
350 Andersson G, Borgquist S, Jirström K. Hormonal factors and pancreatic cancer risk in women: The Malmö Diet and Cancer Study. Int J Cancer 2018;143:52-62. [PMID: 29424426 DOI: 10.1002/ijc.31302] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
351 Engel J, Emeny RT, Hölzel D. Positive lymph nodes do not metastasize. Cancer Metastasis Rev 2012;31:235-46. [PMID: 22198520 DOI: 10.1007/s10555-011-9343-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
352 Japp NC, Souchek JJ, Sasson AR, Hollingsworth MA, Batra SK, Junker WM. Tumor Biomarker In-Solution Quantification, Standard Production, and Multiplex Detection. J Immunol Res 2021;2021:9942605. [PMID: 34514003 DOI: 10.1155/2021/9942605] [Reference Citation Analysis]
353 Loft M, Lee B, Tie J, Gibbs P. Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma. J Pers Med 2019;9:E37. [PMID: 31323810 DOI: 10.3390/jpm9030037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
354 Mlecnik B, Bindea G, Pagès F, Galon J. Tumor immunosurveillance in human cancers. Cancer Metastasis Rev 2011;30:5-12. [PMID: 21249426 DOI: 10.1007/s10555-011-9270-7] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 9.3] [Reference Citation Analysis]
355 Moravec R, Divi R, Verma M. Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression. World J Gastrointest Oncol 2017; 9(6): 235-250 [PMID: 28656074 DOI: 10.4251/wjgo.v9.i6.235] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
356 Lee SY, Haq F, Kim D, Jun C, Jo HJ, Ahn SM, Lee WS. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers. PLoS One. 2014;9:e90459. [PMID: 24599305 DOI: 10.1371/journal.pone.0090459] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 8.8] [Reference Citation Analysis]
357 Szabó A, Merks RM. Cellular potts modeling of tumor growth, tumor invasion, and tumor evolution. Front Oncol 2013;3:87. [PMID: 23596570 DOI: 10.3389/fonc.2013.00087] [Cited by in Crossref: 93] [Cited by in F6Publishing: 69] [Article Influence: 10.3] [Reference Citation Analysis]
358 Woodworth MB, Girskis KM, Walsh CA. Building a lineage from single cells: genetic techniques for cell lineage tracking. Nat Rev Genet 2017;18:230-44. [PMID: 28111472 DOI: 10.1038/nrg.2016.159] [Cited by in Crossref: 151] [Cited by in F6Publishing: 122] [Article Influence: 30.2] [Reference Citation Analysis]
359 Matthaei H, Hong SM, Mayo SC, dal Molin M, Olino K, Venkat R, Goggins M, Herman JM, Edil BH, Wolfgang CL, Cameron JL, Schulick RD, Maitra A, Hruban RH. Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Surg Oncol 2011;18:3493-9. [PMID: 21537863 DOI: 10.1245/s10434-011-1745-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
360 Kohutek ZA, Rosati LM, Hong J, Poling J, Attiyeh MA, Makohon-Moore A, Herman JM, Iacobuzio-Donahue CA. An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course. Cold Spring Harb Mol Case Stud 2017;3:a001701. [PMID: 28679692 DOI: 10.1101/mcs.a001701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
361 Molodysky E, Grant R. Person-to-Person Cancer Transmission via Allogenic Blood Transfusion. Asian Pac J Cancer Prev 2021;22:641-9. [PMID: 33773525 DOI: 10.31557/APJCP.2021.22.3.641] [Reference Citation Analysis]
362 Hunter KW, Amin R, Deasy S, Ha NH, Wakefield L. Genetic insights into the morass of metastatic heterogeneity. Nat Rev Cancer 2018;18:211-23. [PMID: 29422598 DOI: 10.1038/nrc.2017.126] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 19.3] [Reference Citation Analysis]
363 Dodson LF, Hawkins WG, Goedegebuure P. Potential targets for pancreatic cancer immunotherapeutics. Immunotherapy. 2011;3:517-537. [PMID: 21463193 DOI: 10.2217/imt.11.10] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
364 Chroni A, Vu T, Miura S, Kumar S. Delineation of Tumor Migration Paths by Using a Bayesian Biogeographic Approach. Cancers (Basel) 2019;11:E1880. [PMID: 31783570 DOI: 10.3390/cancers11121880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
365 Thompson MJ, Rubbi L, Dawson DW, Donahue TR, Pellegrini M. Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes. PLoS One 2015;10:e0128814. [PMID: 26039411 DOI: 10.1371/journal.pone.0128814] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
366 Antolino L, Rocca M, Todde F, Catarinozzi E, Aurello P, Bollanti L, Ramacciato G, D'Angelo F. Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? Tumori. 2018;104:312-314. [PMID: 29192743 DOI: 10.5301/tj.5000693] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
367 de Wilde RF, Hruban RH, Maitra A, Offerhaus GJA. Reporting precursors to invasive pancreatic cancer: pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm. Diagnostic Histopathology 2012;18:17-30. [DOI: 10.1016/j.mpdhp.2011.10.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
368 Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Zhang J, Sepesi B, Vaporciyan AA, Swisher SG, Heymach JV, Zhang J, Gomez DR, Antonoff MB. Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer. Clin Lung Cancer 2020;21:37-46.e7. [PMID: 31447303 DOI: 10.1016/j.cllc.2019.07.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
369 Hiley CT, Swanton C. Spatial and temporal cancer evolution: causes and consequences of tumour diversity. Clin Med. 2014;14 Suppl 6:s33-s37. [PMID: 25468916 DOI: 10.7861/clinmedicine.14-6-s33] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
370 Sahin IH, Elias H, Chou JF, Capanu M, O'Reilly EM. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior. BMC Cancer 2018;18:769. [PMID: 30055578 DOI: 10.1186/s12885-018-4679-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
371 Song MJ, Lee SH, Kim EY, Chang YS. Increased number of subclones in lung squamous cell carcinoma elicits overexpression of immune related genes. Transl Lung Cancer Res 2020;9:659-69. [PMID: 32676328 DOI: 10.21037/tlcr-19-589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
372 Gore AJ, Deitz SL, Palam LR, Craven KE, Korc M. Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. J Clin Invest 2014;124:338-52. [PMID: 24334458 DOI: 10.1172/JCI71526] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
373 Vu T, Datta PK. Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis. Cancers (Basel) 2017;9:E171. [PMID: 29258163 DOI: 10.3390/cancers9120171] [Cited by in Crossref: 161] [Cited by in F6Publishing: 162] [Article Influence: 32.2] [Reference Citation Analysis]
374 van Roey R, Brabletz T, Stemmler MP, Armstark I. Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer. Front Cell Dev Biol 2021;9:753456. [PMID: 34888306 DOI: 10.3389/fcell.2021.753456] [Reference Citation Analysis]
375 Loeb LA. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer 2011;11:450-7. [PMID: 21593786 DOI: 10.1038/nrc3063] [Cited by in Crossref: 263] [Cited by in F6Publishing: 225] [Article Influence: 23.9] [Reference Citation Analysis]
376 Lean C, Plutynski A. The evolution of failure: explaining cancer as an evolutionary process. Biol Philos 2016;31:39-57. [DOI: 10.1007/s10539-015-9511-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
377 Aboulkheyr Es H, Montazeri L, Aref AR, Vosough M, Baharvand H. Personalized Cancer Medicine: An Organoid Approach. Trends Biotechnol. 2018;36:358-371. [PMID: 29366522 DOI: 10.1016/j.tibtech.2017.12.005] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 21.5] [Reference Citation Analysis]
378 di Magliano MP, Logsdon CD. Roles for KRAS in pancreatic tumor development and progression. Gastroenterology. 2013;144:1220-1229. [PMID: 23622131 DOI: 10.1053/j.gastro.2013.01.071] [Cited by in Crossref: 230] [Cited by in F6Publishing: 218] [Article Influence: 25.6] [Reference Citation Analysis]
379 Notta F, Mullighan CG, Wang JC, Poeppl A, Doulatov S, Phillips LA, Ma J, Minden MD, Downing JR, Dick JE. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 2011;469:362-7. [PMID: 21248843 DOI: 10.1038/nature09733] [Cited by in Crossref: 360] [Cited by in F6Publishing: 327] [Article Influence: 32.7] [Reference Citation Analysis]
380 Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607-620. [PMID: 21620466 DOI: 10.1016/s0140-6736(10)62307-0] [Cited by in Crossref: 1377] [Cited by in F6Publishing: 849] [Article Influence: 125.2] [Reference Citation Analysis]
381 Stearns SC. Evolutionary medicine: its scope, interest and potential. Proc Biol Sci 2012;279:4305-21. [PMID: 22933370 DOI: 10.1098/rspb.2012.1326] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
382 Winter JM, Tang LH, Klimstra DS, Liu W, Linkov I, Brennan MF, D’Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR. Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression. Ann Surg. 2013;258:331-335. [PMID: 23360922 DOI: 10.1097/sla.0b013e31827fe9ce] [Cited by in Crossref: 51] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
383 Mimori K, Saito T, Niida A, Miyano S. Cancer evolution and heterogeneity. Ann Gastroenterol Surg 2018;2:332-8. [PMID: 30238073 DOI: 10.1002/ags3.12182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
384 Watanabe F, Suzuki K, Tamaki S, Abe I, Endo Y, Takayama Y, Ishikawa H, Kakizawa N, Saito M, Futsuhara K, Noda H, Konishi F, Rikiyama T. Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer. PLoS One 2019;14:e0227366. [PMID: 31891652 DOI: 10.1371/journal.pone.0227366] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
385 Farrell JJ. Intraductal papillary mucinous neoplasm to pancreas ductal adenocarcinoma sequence and pancreas cancer screening. Endosc Ultrasound 2018;7:314-8. [PMID: 30323160 DOI: 10.4103/eus.eus_49_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
386 Crnogorac-Jurcevic T, Chelala C, Barry S, Harada T, Bhakta V, Lattimore S, Jurcevic S, Bronner M, Lemoine NR, Brentnall TA. Molecular analysis of precursor lesions in familial pancreatic cancer. PLoS One 2013;8:e54830. [PMID: 23372777 DOI: 10.1371/journal.pone.0054830] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
387 Hamada S, Matsumoto R, Masamune A. HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer. Cancers 2022;14:411. [DOI: 10.3390/cancers14020411] [Reference Citation Analysis]
388 Deharvengt S, Marmarelis M, Korc M. Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer. PLoS One 2012;7:e39684. [PMID: 22761868 DOI: 10.1371/journal.pone.0039684] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
389 Chow K, McCoy P, Stuchbery R, Corcoran NM, Hovens CM. Developments in oligometastatic hormone-sensitive prostate cancer. World J Urol 2019;37:2549-55. [PMID: 30382379 DOI: 10.1007/s00345-018-2542-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
390 Ryu JK, Matthaei H, Dal Molin M, Hong SM, Canto MI, Schulick RD, Wolfgang C, Goggins MG, Hruban RH, Cope L. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology. 2011;11:343-350. [PMID: 21757972 DOI: 10.1159/000 329183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
391 Werner-Klein M, Scheitler S, Hoffmann M, Hodak I, Dietz K, Lehnert P, Naimer V, Polzer B, Treitschke S, Werno C, Markiewicz A, Weidele K, Czyz Z, Hohenleutner U, Hafner C, Haferkamp S, Berneburg M, Rümmele P, Ulmer A, Klein CA. Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma. Nat Commun 2018;9:595. [PMID: 29426936 DOI: 10.1038/s41467-017-02674-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 10.3] [Reference Citation Analysis]
392 Lindquist CM, Miller FH, Hammond NA, Nikolaidis P. Pancreatic cancer screening. Abdom Radiol 2018;43:264-72. [DOI: 10.1007/s00261-017-1308-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
393 Walker EJ, Ko AH, Holly EA, Bracci PM. Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study. Int J Cancer. 2015;136:E646-E653. [PMID: 25091126 DOI: 10.1002/ijc.29120] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
394 Kumar A, Boyle EA, Tokita M, Mikheev AM, Sanger MC, Girard E, Silber JR, Gonzalez-Cuyar LF, Hiatt JB, Adey A, Lee C, Kitzman JO, Born DE, Silbergeld DL, Olson JM, Rostomily RC, Shendure J. Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes. Genome Biol 2014;15:530. [PMID: 25608559 DOI: 10.1186/s13059-014-0530-z] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
395 Morita T, Uzawa N, Mogushi K, Sumino J, Michikawa C, Takahashi K, Myo K, Izumo T, Harada K. Characterizing Genetic Transitions of Copy Number Alterations and Allelic Imbalances in Oral Tongue Carcinoma Metastasis: GENETIC TRANSITIONS IN TONGUE CARCINOMA METASTASIS. Genes Chromosomes Cancer 2016;55:975-86. [DOI: 10.1002/gcc.22395] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
396 Mazor T, Pankov A, Johnson BE, Hong C, Hamilton EG, Bell RJA, Smirnov IV, Reis GF, Phillips JJ, Barnes MJ, Idbaih A, Alentorn A, Kloezeman JJ, Lamfers MLM, Bollen AW, Taylor BS, Molinaro AM, Olshen AB, Chang SM, Song JS, Costello JF. DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors. Cancer Cell 2015;28:307-17. [PMID: 26373278 DOI: 10.1016/j.ccell.2015.07.012] [Cited by in Crossref: 165] [Cited by in F6Publishing: 134] [Article Influence: 23.6] [Reference Citation Analysis]
397 Haebe S, Shree T, Sathe A, Day G, Czerwinski DK, Grimes SM, Lee H, Binkley MS, Long SR, Martin B, Ji HP, Levy R. Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma. Blood 2021;137:2869-80. [PMID: 33728464 DOI: 10.1182/blood.2020009855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
398 Zhou B, Wu Q, Chen G, Zhang T, Zhao Y. NOP14 promotes proliferation and metastasis of pancreatic cancer cells. Cancer Letters 2012;322:195-203. [DOI: 10.1016/j.canlet.2012.03.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
399 Le Large TYS, Bijlsma MF, Kazemier G, van Laarhoven HWM, Giovannetti E, Jimenez CR. Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies. Semin Cancer Biol. 2017;44:153-169. [PMID: 28366542 DOI: 10.1016/j.semcancer.2017.03.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
400 Handelsman Y, Leroith D, Bloomgarden ZT, Dagogo-Jack S, Einhorn D, Garber AJ, Grunberger G, Harrell RM, Gagel RF, Lebovitz HE, McGill JB, Hennekens CH. Diabetes and cancer--an AACE/ACE consensus statement. Endocr Pract. 2013;19:675-693. [PMID: 23978590 DOI: 10.4158/ep13248.cs] [Cited by in Crossref: 64] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
401 Sansregret L, Nepveu A. Gene signatures of genomic instability as prognostic tools for breast cancer. Future Oncol 2011;7:591-4. [PMID: 21568672 DOI: 10.2217/fon.11.34] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
402 Quan L, Dittmar A, Zhou Y, Hutson A, Stassen AP, Demant P. Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice. Genes Chromosomes Cancer 2012;51:631-43. [PMID: 22419448 DOI: 10.1002/gcc.21949] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
403 Bijlsma MF, van Laarhoven HW. The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal. Cancer Metastasis Rev 2015;34:97-114. [PMID: 25566685 DOI: 10.1007/s10555-014-9541-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
404 Natrajan R, Reis-Filho JS. Next-generation sequencing applied to molecular diagnostics. Expert Rev Mol Diagn 2011;11:425-44. [PMID: 21545259 DOI: 10.1586/erm.11.18] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
405 Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M; International Cancer of Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 2013;62:339-47. [PMID: 23135763 DOI: 10.1136/gutjnl-2012-303108] [Cited by in Crossref: 447] [Cited by in F6Publishing: 386] [Article Influence: 44.7] [Reference Citation Analysis]
406 Quante AS, Ming C, Rottmann M, Engel J, Boeck S, Heinemann V, Westphalen CB, Strauch K. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030. Cancer Med 2016;5:2649-56. [PMID: 27356493 DOI: 10.1002/cam4.767] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 14.0] [Reference Citation Analysis]
407 Gall TM, Frampton AE, Krell J, Castellano L, Jiao LR. Circulating molecular markers in pancreatic cancer: ready for clinical use? Future Oncology 2013;9:141-4. [DOI: 10.2217/fon.12.187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
408 Valero V 3rd, Saunders TJ, He J, Weiss MJ, Cameron JL, Dholakia A, Wild AT, Shin EJ, Khashab MA, O'Broin-Lennon AM, Ali SZ, Laheru D, Hruban RH, Iacobuzio-Donahue CA, Herman JM, Wolfgang CL. Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management. Ann Surg 2016;263:153-61. [PMID: 26020105 DOI: 10.1097/SLA.0000000000001156] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
409 Balic A, Dorado J, Alonso-Gómez M, Heeschen C. Stem cells as the root of pancreatic ductal adenocarcinoma. Exp Cell Res 2012;318:691-704. [PMID: 22119145 DOI: 10.1016/j.yexcr.2011.11.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
410 Yates LR, Campbell PJ. Evolution of the cancer genome. Nat Rev Genet 2012;13:795-806. [PMID: 23044827 DOI: 10.1038/nrg3317] [Cited by in Crossref: 394] [Cited by in F6Publishing: 342] [Article Influence: 39.4] [Reference Citation Analysis]
411 Naxerova K, Jain RK. Using tumour phylogenetics to identify the roots of metastasis in humans. Nat Rev Clin Oncol 2015;12:258-72. [DOI: 10.1038/nrclinonc.2014.238] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 12.9] [Reference Citation Analysis]
412 Wirkus J, Ead AS, Mackenzie GG. Impact of dietary fat composition and quantity in pancreatic carcinogenesis: Recent advances and controversies. Nutr Res 2021;88:1-18. [PMID: 33607535 DOI: 10.1016/j.nutres.2020.12.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
413 Huang Y, Gao S, Wu S, Song P, Sun X, Hu X, Zhang S, Yu Y, Zhu J, Li C, Qin Z, Xie L, Yao Q, Tang A, Li Z, Guo G, Wan S, Dong P, Sun L, Li W, Wang D, Gui Y, Yang H, Zhou F, Zhang X, Cai Z. Multilayered molecular profiling supported the monoclonal origin of metastatic renal cell carcinoma. Int J Cancer 2014;135:78-87. [PMID: 24310851 DOI: 10.1002/ijc.28654] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
414 Maeda K, Ding Q, Yoshimitsu M, Kuwahata T, Miyazaki Y, Tsukasa K, Hayashi T, Shinchi H, Natsugoe S, Takao S. CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. Int J Mol Sci 2016;17:E1025. [PMID: 27367674 DOI: 10.3390/ijms17071025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
415 Matsuda Y. Age-related morphological changes in the pancreas and their association with pancreatic carcinogenesis. Pathol Int 2019;69:450-62. [PMID: 31339204 DOI: 10.1111/pin.12837] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
416 Mathur A, Zeiger MA. Genomic medicine for cancer prognosis. J Surg Oncol 2015;111:31-7. [PMID: 25111527 DOI: 10.1002/jso.23734] [Reference Citation Analysis]
417 Speed N, Blair IA. Cyclooxygenase- and lipoxygenase-mediated DNA damage. Cancer Metastasis Rev 2011;30:437-47. [PMID: 22009064 DOI: 10.1007/s10555-011-9298-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
418 Graaf Cd, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, Ahn JM, Liao J, Fletcher MM, Yang D, Brown AJ, Zhou C, Deng J, Wang MW. Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes. Pharmacol Rev 2016;68:954-1013. [PMID: 27630114 DOI: 10.1124/pr.115.011395] [Cited by in Crossref: 153] [Cited by in F6Publishing: 121] [Article Influence: 30.6] [Reference Citation Analysis]
419 Turajlic S, McGranahan N, Swanton C. Inferring mutational timing and reconstructing tumour evolutionary histories. Biochim Biophys Acta. 2015;1855:264-275. [PMID: 25827356 DOI: 10.1016/j.bbcan.2015.03.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
420 Singh RR, O'Reilly EM. New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma. Drugs 2020;80:647-69. [PMID: 32306207 DOI: 10.1007/s40265-020-01304-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
421 Rossi ML, Rehman AA, Gondi CS. Therapeutic options for the management of pancreatic cancer. World J Gastroenterol 2014; 20(32): 11142-11159 [PMID: 25170201 DOI: 10.3748/wjg.v20.i32.11142] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 68] [Article Influence: 9.4] [Reference Citation Analysis]
422 Snuderl M, Fazlollahi L, Le L, Nitta M, Zhelyazkova B, Davidson C, Akhavanfard S, Cahill D, Aldape K, Betensky R, Louis D, Iafrate A. Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma. Cancer Cell 2011;20:810-7. [DOI: 10.1016/j.ccr.2011.11.005] [Cited by in Crossref: 459] [Cited by in F6Publishing: 407] [Article Influence: 41.7] [Reference Citation Analysis]
423 Gao X, Jiang M, Chu Y, Han Y, Jin Y, Zhang W, Wang W, Yang S, Li W, Fan A, Cao J, Wang J, Liu H, Fu X, Chen D, Nie Y, Fan D. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis. Cancer Lett 2022;524:42-56. [PMID: 34582976 DOI: 10.1016/j.canlet.2021.09.026] [Reference Citation Analysis]
424 Miura S, Huuki LA, Buturla T, Vu T, Gomez K, Kumar S. Computational enhancement of single-cell sequences for inferring tumor evolution. Bioinformatics 2018;34:i917-26. [PMID: 30423071 DOI: 10.1093/bioinformatics/bty571] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
425 Takao S, Ding Q, Matsubara S. Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy. J Hepatobiliary Pancreat Sci. 2012;19:614-620. [PMID: 22878838 DOI: 10.1007/s00534-012-0547-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
426 Zhang Y, Chen L, Yang J, Fleming JB, Chiao PJ, Logsdon CD, Li M. Study human pancreatic cancer in mice: how close are they? Biochim Biophys Acta. 2013;1835:110-118. [PMID: 23147198 DOI: 10.1016/j.bbcan.2012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
427 Karunasena E, Sham J, McMahon KW, Ahuja N. Genomics of Peritoneal Malignancies. Surg Oncol Clin N Am 2018;27:463-75. [PMID: 29935683 DOI: 10.1016/j.soc.2018.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
428 Saunus JM, Mccart-reed A, Momeny M, Cummings M, Lakhani SR. Breast Cancer Heterogeneity in Primary and Metastatic Disease. In: Ahmad A, editor. Breast Cancer Metastasis and Drug Resistance. New York: Springer; 2013. pp. 65-95. [DOI: 10.1007/978-1-4614-5647-6_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
429 Zhang J, Fujimoto J, Zhang J, Wedge DC, Song X, Zhang J, Seth S, Chow CW, Cao Y, Gumbs C, Gold KA, Kalhor N, Little L, Mahadeshwar H, Moran C, Protopopov A, Sun H, Tang J, Wu X, Ye Y, William WN, Lee JJ, Heymach JV, Hong WK, Swisher S, Wistuba II, Futreal PA. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science. 2014;346:256-259. [PMID: 25301631 DOI: 10.1126/science.1256930] [Cited by in Crossref: 591] [Cited by in F6Publishing: 555] [Article Influence: 73.9] [Reference Citation Analysis]
430 Neesse A, Krug S, Gress TM, Tuveson DA, Michl P. Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma. Onco Targets Ther. 2013;7:33-43. [PMID: 24379681 DOI: 10.2147/ott.s38111] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
431 Vendramin R, Litchfield K, Swanton C. Cancer evolution: Darwin and beyond. EMBO J 2021;40:e108389. [PMID: 34459009 DOI: 10.15252/embj.2021108389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
432 Tumas J, Kvederaviciute K, Petrulionis M, Kurlinkus B, Rimkus A, Sakalauskaite G, Cicenas J, Sileikis A. Metabolomics in pancreatic cancer biomarkers research. Med Oncol 2016;33:133. [PMID: 27807722 DOI: 10.1007/s12032-016-0853-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
433 Burrell RA, Swanton C. Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol Oncol 2014;8:1095-111. [PMID: 25087573 DOI: 10.1016/j.molonc.2014.06.005] [Cited by in Crossref: 265] [Cited by in F6Publishing: 220] [Article Influence: 33.1] [Reference Citation Analysis]
434 Gaiani F, Marchesi F, Negri F, Greco L, Malesci A, de'Angelis GL, Laghi L. Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes. Int J Mol Sci 2021;22:5246. [PMID: 34063506 DOI: 10.3390/ijms22105246] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
435 Fujita Y, Kitago M, Masugi Y, Itano O, Shinoda M, Abe Y, Hibi T, Yagi H, Fujii-Nishimura Y, Sakamoto M, Kitagawa Y. Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis. World J Gastroenterol 2016; 22(41): 9222-9228 [PMID: 27895409 DOI: 10.3748/wjg.v22.i41.9222] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
436 Hanel W, Moll UM. Links between mutant p53 and genomic instability. J Cell Biochem 2012;113:433-9. [PMID: 22006292 DOI: 10.1002/jcb.23400] [Cited by in Crossref: 112] [Cited by in F6Publishing: 114] [Article Influence: 11.2] [Reference Citation Analysis]
437 Rychlíková J, Vecka M, Jáchymová M, Macášek J, Hrabák P, Zeman M, Vávrová L, Řoupal J, Krechler T, Ák A. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. Cancer Biomark 2016;17:55-65. [PMID: 27314293 DOI: 10.3233/CBM-160617] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
438 Debeljak M, Noë M, Riel SL, Haley LM, Norris AL, Anderson DA, Adams EM, Suenaga M, Beierl KF, Lin MT, Goggins MG, Gocke CD, Eshleman JR. Validation Strategy for Ultrasensitive Mutation Detection. Mol Diagn Ther 2018;22:603-11. [PMID: 29974360 DOI: 10.1007/s40291-018-0350-z] [Reference Citation Analysis]
439 Yang Y, Stang A, Schweickert PG, Lanman NA, Paul EN, Monia BP, Revenko AS, Palumbo JS, Mullins ES, Elzey BD, Janssen EM, Konieczny SF, Flick MJ. Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion. Cancer Res 2019;79:3417-30. [PMID: 31048498 DOI: 10.1158/0008-5472.CAN-18-3206] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
440 Aravindan S, Ramraj SK, Somasundaram ST, Herman TS, Aravindan N. Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer. Stem Cell Res Ther 2015;6:182. [PMID: 26395574 DOI: 10.1186/s13287-015-0173-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
441 Huang HM, Li HX. Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer. Cancer Commun (Lond) 2021;41:91-108. [PMID: 33377623 DOI: 10.1002/cac2.12129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
442 Tamura K, Ohtsuka T, Matsunaga T, Kimura H, Watanabe Y, Ideno N, Aso T, Miyazaki T, Ohuchida K, Takahata S, Ito T, Ushijima Y, Oda Y, Mizumoto K, Tanaka M. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis. Surgery 2015;157:277-84. [DOI: 10.1016/j.surg.2014.09.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
443 Zhou N, Corsini EM, Jin S, Barbosa GR, Kell T, Antonoff MH, Antonoff MB. Advanced Data Analytics for Clinical Research Part II: Application to Cardiothoracic Surgery. Innovations�(Phila) 2020;15:155-62. [DOI: 10.1177/1556984520902824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
444 Burrell RA, Swanton C. The evolution of the unstable cancer genome. Curr Opin Genet Dev. 2014;24:61-67. [PMID: 24657538 DOI: 10.1016/j.gde.2013.11.011] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
445 Song N, Zhou L, Liu W, He X, Pan Z, Ding M, Wan X, Li J, Tan H, Luo F, Fu Q. Effect of trastuzumab on the micellization properties, endocytic pathways and antitumor activities of polyurethane-based drug delivery system. Chin J Polym Sci 2017;35:909-23. [DOI: 10.1007/s10118-017-1952-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
446 Cheng L, Mann SA, Lopez-Beltran A, Chovanec M, Santoni M, Wang M, Albany C, Adra N, Davidson DD, Cimadamore A, Montironi R, Zhang S. Molecular Characterization of Testicular Germ Cell Tumors Using Tissue Microdissection. Methods Mol Biol 2021;2195:31-47. [PMID: 32852755 DOI: 10.1007/978-1-0716-0860-9_3] [Reference Citation Analysis]
447 Humeau M, Torrisani J, Cordelier P. miRNA in clinical practice: Pancreatic cancer. Clinical Biochemistry 2013;46:933-6. [DOI: 10.1016/j.clinbiochem.2013.03.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
448 Schlesinger Y, Yosefov-Levi O, Kolodkin-Gal D, Granit RZ, Peters L, Kalifa R, Xia L, Nasereddin A, Shiff I, Amran O, Nevo Y, Elgavish S, Atlan K, Zamir G, Parnas O. Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells' heterogeneity. Nat Commun 2020;11:4516. [PMID: 32908137 DOI: 10.1038/s41467-020-18207-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
449 Windsor JA, Barreto SG. The concept of 'borderline resectable' pancreatic cancer: limited foundations and limited future? J Gastrointest Oncol 2017;8:189-93. [PMID: 28280624 DOI: 10.21037/jgo.2016.12.06] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
450 Muraro MG, Muenst S, Mele V, Quagliata L, Iezzi G, Tzankov A, Weber WP, Spagnoli GC, Soysal SD. Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments. Oncoimmunology 2017;6:e1331798. [PMID: 28811974 DOI: 10.1080/2162402X.2017.1331798] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
451 Yang L, Li N, Xue Z, Liu LR, Li J, Huang X, Xie X, Zou Y, Tang H, Xie X. Synergistic therapeutic effect of combined PDGFR and SGK1 inhibition in metastasis-initiating cells of breast cancer. Cell Death Differ 2020;27:2066-80. [PMID: 31969692 DOI: 10.1038/s41418-019-0485-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
452 Hamada T, Khalaf N, Yuan C, Babic A, Morales-Oyarvide V, Qian ZR, Nowak JA, Ng K, Kraft P, Rubinson DA, Stampfer MJ, Giovannucci EL, Fuchs CS, Ogino S, Wolpin BM. Statin use and pancreatic cancer risk in two prospective cohort studies. J Gastroenterol. 2018;53:959-966. [PMID: 29362938 DOI: 10.1007/s00535-018-1430-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
453 Jan M, Majeti R. Clonal evolution of acute leukemia genomes. Oncogene 2013;32:135-40. [PMID: 22349821 DOI: 10.1038/onc.2012.48] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 8.0] [Reference Citation Analysis]
454 Korn RL, Rahmanuddin S, Borazanci E. Use of Precision Imaging in the Evaluation of Pancreas Cancer. Cancer Treat Res 2019;178:209-36. [PMID: 31209847 DOI: 10.1007/978-3-030-16391-4_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
455 Jin X, Mu P. Targeting Breast Cancer Metastasis. Breast Cancer (Auckl) 2015;9:23-34. [PMID: 26380552 DOI: 10.4137/BCBCR.S25460] [Cited by in Crossref: 35] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
456 Khalaf N, Yuan C, Hamada T, Cao Y, Babic A, Morales-Oyarvide V, Kraft P, Ng K, Giovannucci E, Ogino S, Stampfer M, Cochrane BB, Manson JE, Clish CB, Chan AT, Fuchs CS, Wolpin BM. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies. Gastroenterology 2018;154:1380-1390.e5. [PMID: 29229401 DOI: 10.1053/j.gastro.2017.12.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
457 Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncologica 2016;55:1158-60. [DOI: 10.1080/0284186x.2016.1197419] [Cited by in Crossref: 115] [Cited by in F6Publishing: 60] [Article Influence: 19.2] [Reference Citation Analysis]
458 Chang MC, Wong JM, Chang YT. Screening and early detection of pancreatic cancer in high risk population. World J Gastroenterol 2014; 20(9): 2358-2364 [PMID: 24605033 DOI: 10.3748/wjg.v20.i9.2358] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
459 Matsuda Y, Seki A, Nonaka K, Kakizaki M, Wang T, Aida J, Ishikawa N, Nakano Y, Kaneda D, Takata T, Takahashi-fujigasaki J, Murayama S, Takubo K, Ishiwata T, Sawabe M, Arai T. Clinicopathological characteristics of distant metastases of adenocarcinoma, squamous cell carcinoma and urothelial carcinoma: An autopsy study of older Japanese patients: Distant metastasis of carcinomas. Geriatr Gerontol Int 2018;18:211-5. [DOI: 10.1111/ggi.13165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
460 Schuhmacher C, Novotny A, Reim D, Ulm K, Friess H. Lymphadenektomie bei Malignomen des oberen Gastrointestinaltraktes. Chirurg 2011;82:1091-5. [DOI: 10.1007/s00104-011-2116-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
461 Gu J, Taylor CR. Practicing pathology in the era of big data and personalized medicine. Appl Immunohistochem Mol Morphol 2014;22:1-9. [PMID: 24326463 DOI: 10.1097/PAI.0000000000000022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 3] [Article Influence: 3.4] [Reference Citation Analysis]
462 Permuth-Wey J, Chen YA, Fisher K, McCarthy S, Qu X, Lloyd MC, Kasprzak A, Fournier M, Williams VL, Ghia KM. A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas. PLoS One. 2015;10:e0116869. [PMID: 25607660 DOI: 10.1371/journal.pone.0116869] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
463 Dzobo K, Senthebane DA, Thomford NE, Rowe A, Dandara C, Parker MI. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development. OMICS 2018;22:17-34. [PMID: 29356626 DOI: 10.1089/omi.2017.0174] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
464 Bennett NC, Farah CS. Next-generation sequencing in clinical oncology: next steps towards clinical validation. Cancers (Basel) 2014;6:2296-312. [PMID: 25412366 DOI: 10.3390/cancers6042296] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
465 Ottenhof NA, de Wilde RF, Maitra A, Hruban RH, Offerhaus GJ. Molecular characteristics of pancreatic ductal adenocarcinoma. Patholog Res Int. 2011;2011:620601. [PMID: 21512581 DOI: 10.4061/2011/620601] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
466 Laura A, Anna C, Cinquepalmi M, Giovanni M, Sole MM, Nava AK, Niccolò P, Giuseppe N, Stefano V, Paolo A, Francesco D, Giovanni R. Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective Studies. J Gastrointest Surg 2020;24:2336-48. [DOI: 10.1007/s11605-020-04697-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
467 Kandagatla P, Maguire LH, Hardiman KM. Biology of Nodal Spread in Colon Cancer: Insights from Molecular and Genetic Studies. Eur Surg Res 2018;59:361-70. [PMID: 30537705 DOI: 10.1159/000494832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
468 Kwon MC, Proost N, Song JY, Sutherland KD, Zevenhoven J, Berns A. Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasis. Genes Dev 2015;29:1587-92. [PMID: 26215568 DOI: 10.1101/gad.262998.115] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
469 Miyawaki T, Kenmotsu H, Kodama H, Nishioka N, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Mori K, Harada H, Endo M, Takahashi K, Takahashi T. Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study. BMC Cancer 2021;21:1247. [PMID: 34798865 DOI: 10.1186/s12885-021-08983-2] [Reference Citation Analysis]
470 Bunganič B, Laclav M, Dvořáková T, Bradáč O, Traboulsi E, Suchánek Š, Frič P, Zavoral M. Accuracy of EUS and CEH EUS for the diagnosis of pancreatic tumours. Scandinavian Journal of Gastroenterology 2018;53:1411-7. [DOI: 10.1080/00365521.2018.1524023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
471 Weigelt B, Reis-filho J, Swanton C. Genomic analyses to select patients for adjuvant chemotherapy: trials and tribulations. Annals of Oncology 2012;23:x211-8. [DOI: 10.1093/annonc/mds323] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
472 Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17:351-359. [PMID: 25774832 DOI: 10.1038/ncb3124] [Cited by in Crossref: 657] [Cited by in F6Publishing: 624] [Article Influence: 93.9] [Reference Citation Analysis]
473 Ishiwata T, Matsuda Y, Yamamoto T, Uchida E, Korc M, Naito Z. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation. Am J Pathol 2012;180:1928-41. [PMID: 22440254 DOI: 10.1016/j.ajpath.2012.01.020] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
474 Hanada K, Fukuhara M, Minami T, Yano S, Ikemoto J, Shimizu A, Kurihara K, Okuda Y, Ikeda M, Yokode M, Abe T, Yonehara S, Yanagisawa A. Pathological Features and Imaging Findings in Pancreatic Carcinoma In Situ. Pancreas 2021;50:399-404. [PMID: 33835972 DOI: 10.1097/MPA.0000000000001771] [Reference Citation Analysis]
475 Sato A, Masui T, Yogo A, Ito T, Hirakawa K, Kanawaku Y, Koike K, Uemoto S. Time-frequency analysis of serum with proton nuclear magnetic resonance for diagnosis of pancreatic cancer. Sci Rep 2020;10:21941. [PMID: 33318606 DOI: 10.1038/s41598-020-79087-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
476 Maekawa T, Fukaya R, Takamatsu S, Itoyama S, Fukuoka T, Yamada M, Hata T, Nagaoka S, Kawamoto K, Eguchi H, Murata K, Kumada T, Ito T, Tanemura M, Fujimoto K, Tomita Y, Tobe T, Kamada Y, Miyoshi E. Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancer. Biochem Biophys Res Commun. 2018;506:962-969. [PMID: 30401562 DOI: 10.1016/j.bbrc.2018.10.169] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
477 Schiffman JD, Geller JI, Mundt E, Means A, Means L, Means V. Update on pediatric cancer predisposition syndromes. Pediatr Blood Cancer 2013;60:1247-52. [PMID: 23625733 DOI: 10.1002/pbc.24555] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
478 Roth B, Jayaratna I, Sundi D, Cheng T, Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M, Guo C, Czerniak B, McConkey D, Dinney C. Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. Oncotarget 2017;8:34205-22. [PMID: 27494900 DOI: 10.18632/oncotarget.11009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
479 Lapin M, Tjensvoll K, Oltedal S, Javle M, Smaaland R, Gilje B, Nordgård O. Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells. BMC Cancer 2017;17:390. [PMID: 28569190 DOI: 10.1186/s12885-017-3385-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
480 Trivieri N, Panebianco C, Villani A, Pracella R, Latiano TP, Perri F, Binda E, Pazienza V. High Levels of Prebiotic Resistant Starch in Diet Modulate a Specific Pattern of miRNAs Expression Profile Associated to a Better Overall Survival in Pancreatic Cancer. Biomolecules 2020;11:E26. [PMID: 33383727 DOI: 10.3390/biom11010026] [Reference Citation Analysis]
481 Kobashi Y, Uchiyama M, Matsui J. The "K-Sign"-A Novel CT Finding Suggestive before the Appearance of Pancreatic Cancer. Cancers (Basel) 2021;13:4222. [PMID: 34439375 DOI: 10.3390/cancers13164222] [Reference Citation Analysis]
482 Corces-Zimmerman MR, Majeti R. Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis. Leukemia 2014;28:2276-82. [PMID: 25005245 DOI: 10.1038/leu.2014.211] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 10.5] [Reference Citation Analysis]
483 Dancey JE, Bedard PL, Onetto N, Hudson TJ. The genetic basis for cancer treatment decisions. Cell. 2012;148:409-420. [PMID: 22304912 DOI: 10.1016/j.cell.2012.01.014] [Cited by in Crossref: 214] [Cited by in F6Publishing: 175] [Article Influence: 21.4] [Reference Citation Analysis]
484 Langley RR, Fidler IJ. The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 2011;128:2527-2535. [PMID: 21365651 DOI: 10.1002/ijc.26031] [Cited by in Crossref: 481] [Cited by in F6Publishing: 458] [Article Influence: 43.7] [Reference Citation Analysis]
485 Cancer Communications. The 150 most important questions in cancer research and clinical oncology series: questions 94-101 : Edited by Cancer Communications. Cancer Commun (Lond) 2018;38:69. [PMID: 30477575 DOI: 10.1186/s40880-018-0341-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
486 Ma X, Becker Buscaglia LE, Barker JR, Li Y. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 2011;3:159-66. [PMID: 21502305 DOI: 10.1093/jmcb/mjr007] [Cited by in Crossref: 405] [Cited by in F6Publishing: 398] [Article Influence: 36.8] [Reference Citation Analysis]
487 Sun R, Hu Z, Curtis C. Big Bang Tumor Growth and Clonal Evolution. Cold Spring Harb Perspect Med 2018;8:a028381. [PMID: 28710260 DOI: 10.1101/cshperspect.a028381] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
488 Song F, Li X, Song F, Zhao Y, Li H, Zheng H, Gao Z, Wang J, Zhang W, Chen K. Comparative genomic analysis reveals bilateral breast cancers are genetically independent. Oncotarget 2015;6:31820-9. [PMID: 26378809 DOI: 10.18632/oncotarget.5569] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
489 Yadav DK, Bai X, Yadav RK, Singh A, Li G, Ma T, Chen W, Liang T. Liquid biopsy in pancreatic cancer: the beginning of a new era. Oncotarget 2018;9:26900-33. [PMID: 29928492 DOI: 10.18632/oncotarget.24809] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
490 Gu L, Mooney DJ. Biomaterials and emerging anticancer therapeutics: engineering the microenvironment. Nat Rev Cancer 2016;16:56-66. [PMID: 26694936 DOI: 10.1038/nrc.2015.3] [Cited by in Crossref: 224] [Cited by in F6Publishing: 202] [Article Influence: 37.3] [Reference Citation Analysis]
491 McFadden DG, Papagiannakopoulos T, Taylor-Weiner A, Stewart C, Carter SL, Cibulskis K, Bhutkar A, McKenna A, Dooley A, Vernon A, Sougnez C, Malstrom S, Heimann M, Park J, Chen F, Farago AF, Dayton T, Shefler E, Gabriel S, Getz G, Jacks T. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell 2014;156:1298-311. [PMID: 24630729 DOI: 10.1016/j.cell.2014.02.031] [Cited by in Crossref: 174] [Cited by in F6Publishing: 159] [Article Influence: 21.8] [Reference Citation Analysis]
492 Bidard F, Poupon M. Biologie du processus métastatique. Med Sci (Paris) 2012;28:89-95. [DOI: 10.1051/medsci/2012281022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
493 Kim J, Zaret KS. Reprogramming of human cancer cells to pluripotency for models of cancer progression. EMBO J 2015;34:739-47. [PMID: 25712212 DOI: 10.15252/embj.201490736] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
494 Zhang YP, Wan YD, Sun YL, Li J, Zhu RT. Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies. Sci Rep 2015;5:15460. [PMID: 26486090 DOI: 10.1038/srep15460] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
495 Allen B, Nowak MA. Evolutionary shift dynamics on a cycle. J Theor Biol 2012;311:28-39. [PMID: 22814475 DOI: 10.1016/j.jtbi.2012.07.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
496 Whitcomb DC, Shelton CA, Brand RE. Genetics and Genetic Testing in Pancreatic Cancer. Gastroenterology. 2015;149:1252-1264.e4. [PMID: 26255042 DOI: 10.1053/j.gastro.2015.07.057] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
497 Swayden M, Iovanna J, Soubeyran P. Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype. Heliyon 2018;4:e01055. [PMID: 30582059 DOI: 10.1016/j.heliyon.2018.e01055] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
498 Koopmann BD, Harinck F, Kroep S, Konings IC, Naber SK, Lansdorp-Vogelaar I, Fockens P, van Hooft JE, Cahen DL, van Ballegooijen M, Bruno MJ, de Kok IM. Identifying key factors for the effectiveness of pancreatic cancer screening: A model-based analysis. Int J Cancer. 2021;. [PMID: 33644856 DOI: 10.1002/ijc.33540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
499 Shibata T. Cancer genomics and pathology: All Together Now: Cancer genomics and pathology. Pathology International 2012;62:647-59. [DOI: 10.1111/j.1440-1827.2012.02855.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
500 Takahashi K, Ehata S, Koinuma D, Morishita Y, Soda M, Mano H, Miyazono K. Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells. Oncogene 2018;37:2757-72. [PMID: 29511349 DOI: 10.1038/s41388-018-0144-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
501 Cowan RW, Pratt ED, Kang JM, Zhao J, Wilhelm JJ, Abdulla M, Qiao EM, Brennan LP, Ulintz PJ, Bellin MD, Rhim AD. Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic Pancreatitis. Clin Transl Gastroenterol 2021;12:e00431. [PMID: 34797250 DOI: 10.14309/ctg.0000000000000431] [Reference Citation Analysis]
502 Hindriksen S, Bijlsma MF. Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors. Cancers (Basel) 2012;4:989-1035. [PMID: 24213498 DOI: 10.3390/cancers4040989] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
503 Hilmer AJ, Jeffrey RB, Park WG, Khosla C. Cholestyramine as a promising, strong anion exchange resin for direct capture of genetic biomarkers from raw pancreatic fluids. Biotechnol Bioeng 2017;114:934-8. [PMID: 27800600 DOI: 10.1002/bit.26207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
504 Arundhathi A, Chuang WH, Chen JK, Wang SE, Shyr YM, Chen JY, Liao WN, Chen HW, Teng YM, Pai CC, Wang CH. Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis. Oncotarget 2016;7:55437-48. [PMID: 28874965 DOI: 10.18632/oncotarget.10583] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
505 Werner RA, Ilhan H, Lehner S, Papp L, Zsótér N, Schatka I, Muegge DO, Javadi MS, Higuchi T, Buck AK, Bartenstein P, Bengel F, Essler M, Lapa C, Bundschuh RA. Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy. Mol Imaging Biol 2019;21:582-90. [DOI: 10.1007/s11307-018-1252-5] [Reference Citation Analysis]
506 Cruz-Monserrate Z, Conwell DL, Krishna SG. The Impact of Obesity on Gallstone Disease, Acute Pancreatitis, and Pancreatic Cancer. Gastroenterol Clin North Am 2016;45:625-37. [PMID: 27837777 DOI: 10.1016/j.gtc.2016.07.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
507 Yuan C, Clish CB, Wu C, Mayers JR, Kraft P, Townsend MK, Zhang M, Tworoger SS, Bao Y, Qian ZR, Rubinson DA, Ng K, Giovannucci EL, Ogino S, Stampfer MJ, Gaziano JM, Ma J, Sesso HD, Anderson GL, Cochrane BB, Manson JE, Torrence ME, Kimmelman AC, Amundadottir LT, Vander Heiden MG, Fuchs CS, Wolpin BM. Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. J Natl Cancer Inst 2016;108:djv409. [PMID: 26755275 DOI: 10.1093/jnci/djv409] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
508 Yachida S, Wood LD, Suzuki M, Takai E, Totoki Y, Kato M, Luchini C, Arai Y, Nakamura H, Hama N, Elzawahry A, Hosoda F, Shirota T, Morimoto N, Hori K, Funazaki J, Tanaka H, Morizane C, Okusaka T, Nara S, Shimada K, Hiraoka N, Taniguchi H, Higuchi R, Oshima M, Okano K, Hirono S, Mizuma M, Arihiro K, Yamamoto M, Unno M, Yamaue H, Weiss MJ, Wolfgang CL, Furukawa T, Nakagama H, Vogelstein B, Kiyono T, Hruban RH, Shibata T. Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma. Cancer Cell. 2016;29:229-240. [PMID: 26806338 DOI: 10.1016/j.ccell.2015.12.012] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 13.2] [Reference Citation Analysis]
509 Han R, Huang G, Wang Y, Xu Y, Hu Y, Jiang W, Wang T, Xiao T, Zheng D. Increased gene expression noise in human cancers is correlated with low p53 and immune activities as well as late stage cancer. Oncotarget 2016;7:72011-20. [PMID: 27713130 DOI: 10.18632/oncotarget.12457] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
510 Ebrahimi S, Nonacs P. Genetic diversity through social heterosis can increase virulence in RNA viral infections and cancer progression. R Soc Open Sci 2021;8:202219. [PMID: 34035948 DOI: 10.1098/rsos.202219] [Reference Citation Analysis]
511 White RM. Genomic Approaches to Zebrafish Cancer. Adv Exp Med Biol 2016;916:125-45. [PMID: 27165352 DOI: 10.1007/978-3-319-30654-4_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
512 Josephidou M, Lynch AG, Tavaré S. multiSNV: a probabilistic approach for improving detection of somatic point mutations from multiple related tumour samples. Nucleic Acids Res 2015;43:e61. [PMID: 25722372 DOI: 10.1093/nar/gkv135] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
513 Yoshioka KI, Matsuno Y, Hyodo M, Fujimori H. Genomic-Destabilization-Associated Mutagenesis and Clonal Evolution of Cells with Mutations in Tumor-Suppressor Genes. Cancers (Basel) 2019;11:E1643. [PMID: 31653100 DOI: 10.3390/cancers11111643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
514 Masugi Y, Abe T, Ueno A, Fujii-Nishimura Y, Ojima H, Endo Y, Fujita Y, Kitago M, Shinoda M, Kitagawa Y, Sakamoto M. Characterization of spatial distribution of tumor-infiltrating CD8+ T cells refines their prognostic utility for pancreatic cancer survival. Mod Pathol 2019;32:1495-507. [PMID: 31186528 DOI: 10.1038/s41379-019-0291-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
515 Qian JJ, Akçay E. Competition and niche construction in a model of cancer metastasis. PLoS One 2018;13:e0198163. [PMID: 29813117 DOI: 10.1371/journal.pone.0198163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
516 Miyawaki T, Wakuda K, Kenmotsu H, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ono A, Naito T, Murakami H, Notsu A, Mori K, Harada H, Endo M, Ohde Y, Takahashi K, Takahashi T. Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy. Cancer Sci 2021;112:359-68. [PMID: 33098119 DOI: 10.1111/cas.14707] [Reference Citation Analysis]
517 Vleeschouwer SD, Bergers G; Department of Neurosurgery, University Hospitals Leuven, Leuven, Belgium, VIB-KU Leuven Center for Cancer Biology, Campus Gasthuisberg, Leuven, Belgium. Glioblastoma: To Target the Tumor Cell or the Microenvironment? In: De Vleeschouwer S, editor. Glioblastoma. Codon Publications; 2017. pp. 315-40. [DOI: 10.15586/codon.glioblastoma.2017.ch16] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
518 Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature 2013;501:328-37. [PMID: 24048065 DOI: 10.1038/nature12624] [Cited by in Crossref: 1323] [Cited by in F6Publishing: 1202] [Article Influence: 147.0] [Reference Citation Analysis]
519 Okabayashi T, Shima Y, Kosaki T, Sumiyoshi T, Kozuki A, Iiyama T, Takezaki Y, Kobayashi M, Nishimori I, Ogawa Y, Hanazaki K. Invasive carcinoma derived from branch duct-type IPMN may be a more aggressive neoplasm than that derived from main duct-type IPMN. Oncol Lett. 2013;5:1819-1825. [PMID: 23833648 DOI: 10.3892/ol.2013.1268] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
520 Paiella S, Capurso G, Cavestro GM, Butturini G, Pezzilli R, Salvia R, Signoretti M, Crippa S, Carrara S, Frigerio I, Bassi C, Falconi M, Iannicelli E, Giardino A, Mannucci A, Laghi A, Laghi L, Frulloni L, Zerbi A. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry. Am J Gastroenterol 2019;114:665-70. [DOI: 10.1038/s41395-018-0414-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
521 Kuruma S, Kikuyama M, Chiba K, Yoshimoto K, Kamisawa T, Honda G, Horiguchi S, Nakahodo J. Carcinoma in situ of the pancreas with pancreatic duct stricture persistent for 4 years diagnosed by serial pancreatic juice aspiration cytologic examination (SPACE). Clin J Gastroenterol 2020;13:443-7. [PMID: 31768883 DOI: 10.1007/s12328-019-01065-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
522 Gerstung M, Eriksson N, Lin J, Vogelstein B, Beerenwinkel N. The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One 2011;6:e27136. [PMID: 22069497 DOI: 10.1371/journal.pone.0027136] [Cited by in Crossref: 84] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
523 Burdyga A, Conant A, Haynes L, Zhang J, Jalink K, Sutton R, Neoptolemos J, Costello E, Tepikin A. cAMP inhibits migration, ruffling and paxillin accumulation in focal adhesions of pancreatic ductal adenocarcinoma cells: effects of PKA and EPAC. Biochim Biophys Acta 2013;1833:2664-72. [PMID: 23797058 DOI: 10.1016/j.bbamcr.2013.06.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
524 Gold B, Cankovic M, Furtado LV, Meier F, Gocke CD. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? J Mol Diagn. 2015;17:209-224. [PMID: 25908243 DOI: 10.1016/j.jmoldx.2015.02.001] [Cited by in Crossref: 121] [Cited by in F6Publishing: 112] [Article Influence: 20.2] [Reference Citation Analysis]
525 Gomez DR, Niibe Y, Chang JY. Oligometastatic disease at presentation or recurrence for nonsmall cell lung cancer. Pulm Med 2012;2012:396592. [PMID: 22900169 DOI: 10.1155/2012/396592] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
526 Cheema AR, O’reilly EM. Management of Metastatic Pancreatic Adenocarcinoma. Surgical Clinics of North America 2016;96:1391-414. [DOI: 10.1016/j.suc.2016.07.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
527 Goto T, Hirotsu Y, Amemiya K, Mochizuki H, Omata M. Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach. Cancers (Basel) 2018;10:E212. [PMID: 29932159 DOI: 10.3390/cancers10070212] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
528 Lennon AM, Wolfgang CL, Canto MI, Klein AP, Herman JM, Goggins M, Fishman EK, Kamel I, Weiss MJ, Diaz LA, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH. The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia? Cancer Res 2014;74:3381-9. [DOI: 10.1158/0008-5472.can-14-0734] [Cited by in Crossref: 144] [Cited by in F6Publishing: 80] [Article Influence: 18.0] [Reference Citation Analysis]
529 Resovi A, Bani MR, Porcu L, Anastasia A, Minoli L, Allavena P, Cappello P, Novelli F, Scarpa A, Morandi E, Falanga A, Torri V, Taraboletti G, Belotti D, Giavazzi R. Soluble stroma-related biomarkers of pancreatic cancer. EMBO Mol Med 2018;10:e8741. [PMID: 29941541 DOI: 10.15252/emmm.201708741] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
530 Kato H, Tateishi K, Fujiwara H, Ijichi H, Yamamoto K, Nakatsuka T, Kakiuchi M, Sano M, Kudo Y, Hayakawa Y, Nakagawa H, Tanaka Y, Otsuka M, Hirata Y, Tachibana M, Shinkai Y, Koike K. Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis. Cancer Genomics Proteomics 2020;17:695-705. [PMID: 33099471 DOI: 10.21873/cgp.20224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
531 Ma QC, Ennis CA, Aparicio S. Opening Pandora's Box—the new biology of driver mutations and clonal evolution in cancer as revealed by next generation sequencing. Current Opinion in Genetics & Development 2012;22:3-9. [DOI: 10.1016/j.gde.2012.01.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
532 Wang L, Wang X, Jia Y, Guo F, Zhengjun S, Shao Z. Intratumoural heterogeneity and clone evolution of oral squamous cell carcinoma. Mol Carcinog 2021;60:758-68. [PMID: 34432915 DOI: 10.1002/mc.23341] [Reference Citation Analysis]
533 Ocaña A, Freedman O, Amir E, Seruga B, Pandiella A. Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors. Cancer Metastasis Rev 2014;33:295-307. [PMID: 24338003 DOI: 10.1007/s10555-013-9451-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
534 Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SG, Hoadley KA, Rashid NU, Williams LA, Eaton SC, Chung AH, Smyla JK, Anderson JM, Kim HJ, Bentrem DJ, Talamonti MS, Iacobuzio-Donahue CA, Hollingsworth MA, Yeh JJ. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet 2015;47:1168-78. [PMID: 26343385 DOI: 10.1038/ng.3398] [Cited by in Crossref: 765] [Cited by in F6Publishing: 670] [Article Influence: 109.3] [Reference Citation Analysis]
535 Miller HC, Drymousis P, Flora R, Goldin R, Spalding D, Frilling A. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease. World J Surg. 2014;38:1353-1361. [PMID: 24493070 DOI: 10.1007/s00268-014-2451-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
536 Du Y, Zhao B, Liu Z, Ren X, Zhao W, Li Z, You L, Zhao Y. Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic. J Cancer 2017;8:513-22. [PMID: 28367231 DOI: 10.7150/jca.17622] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
537 Tomlinson K, Oesper L. Parameter, noise, and tree topology effects in tumor phylogeny inference. BMC Med Genomics 2019;12:184. [PMID: 31865909 DOI: 10.1186/s12920-019-0626-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
538 Robsahm TE, Tretli S, Torjesen PA, Babigumira R, Schwartz GG. Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis. Clin Epidemiol 2019;11:695-705. [PMID: 31496824 DOI: 10.2147/CLEP.S207230] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
539 Antal T, Krapivsky PL, Nowak MA. Spatial evolution of tumors with successive driver mutations. Phys Rev E Stat Nonlin Soft Matter Phys 2015;92:022705. [PMID: 26382430 DOI: 10.1103/PhysRevE.92.022705] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
540 Tang Q, Moore JC, Ignatius MS, Tenente IM, Hayes MN, Garcia EG, Torres Yordán N, Bourque C, He S, Blackburn JS, Look AT, Houvras Y, Langenau DM. Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish. Nat Commun 2016;7:10358. [PMID: 26790525 DOI: 10.1038/ncomms10358] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 9.7] [Reference Citation Analysis]
541 Hackeng WM, Hruban RH, Offerhaus GJ, Brosens LA. Surgical and molecular pathology of pancreatic neoplasms. Diagn Pathol 2016;11:47. [PMID: 27267993 DOI: 10.1186/s13000-016-0497-z] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 9.7] [Reference Citation Analysis]
542 Lei Y, Tang R, Xu J, Wang W, Zhang B, Liu J, Yu X, Shi S. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol 2021;14:91. [PMID: 34108022 DOI: 10.1186/s13045-021-01105-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
543 Tanaka M, Ishikawa S, Ushiku T, Morikawa T, Isagawa T, Yamagishi M, Yamamoto H, Katoh H, Takeshita K, Arita J, Sakamoto Y, Hasegawa K, Kokudo N, Fukayama M. EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis. Oncotarget 2017;8:99552-66. [PMID: 29245923 DOI: 10.18632/oncotarget.20601] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
544 Iacobuzio-Donahue CA. Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project. Gut. 2012;61:1085-1094. [PMID: 21749982 DOI: 10.1136/gut.2010.236026] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 8.1] [Reference Citation Analysis]
545 Pappalardo A, Giunta EF, Tirino G, Pompella L, Federico P, Daniele B, De Vita F, Petrillo A. Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting. Front Oncol 2021;11:695627. [PMID: 34485130 DOI: 10.3389/fonc.2021.695627] [Reference Citation Analysis]
546 Kenner BJ. Early Detection of Pancreatic Cancer: The Role of Depression and Anxiety as a Precursor for Disease. Pancreas 2018;47:363-7. [PMID: 29498966 DOI: 10.1097/MPA.0000000000001024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
547 Chui MH. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step. Int J Cancer. 2013;132:1487-1495. [PMID: 22833228 DOI: 10.1002/ijc.27745] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 7.3] [Reference Citation Analysis]
548 Braat H, Bruno M, Kuipers EJ, Peppelenbosch MP. Pancreatic cancer: promise for personalised medicine? Cancer Lett 2012;318:1-8. [PMID: 22178657 DOI: 10.1016/j.canlet.2011.11.034] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
549 Gehlert S. Forging an integrated agenda for primary cancer prevention during midlife. Am J Prev Med 2014;46:S104-9. [PMID: 24512926 DOI: 10.1016/j.amepre.2013.12.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
550 Philip B, Roland CL, Daniluk J, Liu Y, Chatterjee D, Gomez SB, Ji B, Huang H, Wang H, Fleming JB, Logsdon CD, Cruz-Monserrate Z. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology. 2013;145:1449-1458. [PMID: 23958541 DOI: 10.1053/j.gastro.2013.08.018] [Cited by in Crossref: 134] [Cited by in F6Publishing: 126] [Article Influence: 14.9] [Reference Citation Analysis]
551 Kumar-Sinha C, Wei I, Simeone DM. Emerging frontiers in pancreatic cancer research: elaboration of key genes, cells and the extracellular milieu. Curr Opin Gastroenterol. 2012;28:516-522. [PMID: 22759592 DOI: 10.1097/mog.0b013e3283567f69] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
552 Boulaiz H, Ramos MC, Griñán-Lisón C, García-Rubiño ME, Vicente F, Marchal JA. What's new in the diagnosis of pancreatic cancer: a patent review (2011-present). Expert Opin Ther Pat 2017;27:1319-28. [PMID: 28929814 DOI: 10.1080/13543776.2017.1379991] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
553 Matthaei H, Feldmann G, Lingohr P, Kalff JC. Molecular diagnostics of pancreatic cysts. Langenbecks Arch Surg 2013;398:1021-7. [DOI: 10.1007/s00423-013-1116-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
554 Hanada K, Amano H, Abe T. Early diagnosis of pancreatic cancer: Current trends and concerns. Ann Gastroenterol Surg 2017;1:44-51. [PMID: 29863166 DOI: 10.1002/ags3.12004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
555 Wang J, Paris PL, Chen J, Ngo V, Yao H, Frazier ML, Killary AM, Liu CG, Liang H, Mathy C, Bondada S, Kirkwood K, Sen S. Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions. Cancer Lett. 2015;356:404-409. [PMID: 25304377 DOI: 10.1016/j.canlet.2014.09.029] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
556 Hidalgo M, Amant F, Biankin AV, Budinská E, Byrne AT, Caldas C, Clarke RB, de Jong S, Jonkers J, Mælandsmo GM, Roman-Roman S, Seoane J, Trusolino L, Villanueva A. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov 2014;4:998-1013. [PMID: 25185190 DOI: 10.1158/2159-8290.CD-14-0001] [Cited by in Crossref: 863] [Cited by in F6Publishing: 552] [Article Influence: 107.9] [Reference Citation Analysis]
557 Stoletov K, Beatty PH, Lewis JD. Novel therapeutic targets for cancer metastasis. Expert Rev Anticancer Ther 2020;20:97-109. [PMID: 31997674 DOI: 10.1080/14737140.2020.1718496] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
558 Aguilar H, Sanchez E, Braña I, Vivancos A, Rodon J. Molecular screening programmes for precision medicine: lessons learned from personalized medicine trials. Expert Review of Precision Medicine and Drug Development 2016;1:419-30. [DOI: 10.1080/23808993.2016.1238285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
559 Ma Y, Li G, Hu J, Liu X, Shi B. MicroRNA-494 regulates Gli3 expression and inhibits pancreatic cancer cells growth and migration. J Cell Biochem 2018;119:5324-31. [PMID: 29315756 DOI: 10.1002/jcb.26658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
560 Heits N, Brosch M, Herrmann A, Behrens R, Röcken C, Schrem H, Kaltenborn A, Klempnauer J, Kreipe HH, Reichert B, Lenschow C, Wilms C, Vogel T, Wolters H, Wardelmann E, Seehofer D, Buch S, Zeissig S, Pannach S, Raschzok N, Dietel M, von Schoenfels W, Hinz S, Teufel A, Evert M, Franke A, Becker T, Braun F, Hampe J, Schafmayer C. Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular Carcinoma. Transplantation 2018;102:e424-30. [PMID: 29994984 DOI: 10.1097/TP.0000000000002356] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
561 Waclaw B, Bozic I, Pittman ME, Hruban RH, Vogelstein B, Nowak MA. A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. Nature 2015;525:261-4. [PMID: 26308893 DOI: 10.1038/nature14971] [Cited by in Crossref: 317] [Cited by in F6Publishing: 251] [Article Influence: 45.3] [Reference Citation Analysis]
562 Tuveson DA, Neoptolemos JP. Understanding metastasis in pancreatic cancer: a call for new clinical approaches. Cell. 2012;148:21-23. [PMID: 22265397 DOI: 10.1016/j.cell.2011.12.021] [Cited by in Crossref: 118] [Cited by in F6Publishing: 116] [Article Influence: 11.8] [Reference Citation Analysis]
563 Li F, Li C, Zhang H, Lu Z, Li Z, You Q, Lu N, Guo Q. VI-14, a novel flavonoid derivative, inhibits migration and invasion of human breast cancer cells. Toxicol Appl Pharmacol 2012;261:217-26. [PMID: 22538171 DOI: 10.1016/j.taap.2012.04.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
564 Meeks JJ, Al-Ahmadie H, Faltas BM, Taylor JA 3rd, Flaig TW, DeGraff DJ, Christensen E, Woolbright BL, McConkey DJ, Dyrskjøt L. Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes. Nat Rev Urol 2020;17:259-70. [PMID: 32235944 DOI: 10.1038/s41585-020-0304-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
565 Hoskins JW, Jia J, Flandez M, Parikh H, Xiao W, Collins I, Emmanuel MA, Ibrahim A, Powell J, Zhang L, Malats N, Bamlet WR, Petersen GM, Real FX, Amundadottir LT. Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A. Carcinogenesis 2014;35:2670-8. [PMID: 25233928 DOI: 10.1093/carcin/bgu193] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
566 Zhou B, Xu JW, Cheng YG, Gao JY, Hu SY, Wang L, Zhan HX. Early detection of pancreatic cancer: Where are we now and where are we going? Int J Cancer. 2017;141:231-241. [PMID: 28240774 DOI: 10.1002/ijc.30670] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 15.8] [Reference Citation Analysis]
567 Kunz M. Oncogenes in melanoma: an update. Eur J Cell Biol 2014;93:1-10. [PMID: 24468268 DOI: 10.1016/j.ejcb.2013.12.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
568 Nolen BM, Brand RE, Prosser D, Velikokhatnaya L, Allen PJ, Zeh HJ, Grizzle WE, Huang Y, Lomakin A, Lokshin AE. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. PLoS One. 2014;9:e94928. [PMID: 24747429 DOI: 10.1371/journal.pone.0094928] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
569 Vang S, Wu HT, Fischer A, Miller DH, MacLaughlan S, Douglass E, Steinhoff M, Collins C, Smith PJ, Brard L. Identification of ovarian cancer metastatic miRNAs. PLoS One. 2013;8:e58226. [PMID: 23554878 DOI: 10.1371/journal.pone.0058226] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 7.0] [Reference Citation Analysis]
570 Burrell RA, Swanton C. Re-Evaluating Clonal Dominance in Cancer Evolution. Trends Cancer 2016;2:263-76. [PMID: 28741512 DOI: 10.1016/j.trecan.2016.04.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
571 Huerta M, Roselló S, Sabater L, Ferrer A, Tarazona N, Roda D, Gambardella V, Alfaro-Cervelló C, Garcés-Albir M, Cervantes A, Ibarrola-Villava M. Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review. Cancers (Basel) 2021;13:994. [PMID: 33673558 DOI: 10.3390/cancers13050994] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
572 Lorenzo D, Rebours V, Maire F, Palazzo M, Gonzalez JM, Vullierme MP, Aubert A, Hammel P, Lévy P, Mestier L. Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer. World J Gastroenterol 2019; 25(34): 5082-5096 [PMID: 31558858 DOI: 10.3748/wjg.v25.i34.5082] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
573 Markowitz SD. Cancer bypasses the lymph nodes. Science 2017;357:35-6. [PMID: 28684492 DOI: 10.1126/science.aan8299] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
574 Ischenko I, Petrenko O, Hayman MJ. A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells. Oncotarget 2015;6:15814-27. [PMID: 26158412 DOI: 10.18632/oncotarget.4538] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
575 Navai SA, Ahmed N. Targeting the tumour profile using broad spectrum chimaeric antigen receptor T-cells. Biochem Soc Trans 2016;44:391-6. [PMID: 27068945 DOI: 10.1042/BST20150266] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
576 Ponz-Sarvise M, Tuveson DA, Yu KH. Mouse Models of Pancreatic Ductal Adenocarcinoma. Hematol Oncol Clin North Am 2015;29:609-17. [PMID: 26226900 DOI: 10.1016/j.hoc.2015.04.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
577 Thomas SK, Lee J, Beatty GL. Paracrine and cell autonomous signalling in pancreatic cancer progression and metastasis. EBioMedicine. 2020;53:102662. [PMID: 32139180 DOI: 10.1016/j.ebiom.2020.102662] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
578 Kwong GA, Ghosh S, Gamboa L, Patriotis C, Srivastava S, Bhatia SN. Synthetic biomarkers: a twenty-first century path to early cancer detection. Nat Rev Cancer 2021;21:655-68. [PMID: 34489588 DOI: 10.1038/s41568-021-00389-3] [Reference Citation Analysis]
579 Moutinho-Ribeiro P, Costa-Moreira P, Adem B, Batista I, Almeida M, Barroca H, Lopes J, Carneiro F, Melo SA, Macedo G. Exosomal glypican-1 for risk stratification of pancreatic cystic lesions: A case of pathological progression in the absence of any suspicious imaging finding. Pancreatology 2020;20:571-5. [PMID: 32024605 DOI: 10.1016/j.pan.2020.01.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
580 Chronopoulos A, Lieberthal TJ, del Río Hernández AE. Exosomes as a platform for ‘liquid biopsy’ in pancreatic cancer. Converg Sci Phys Oncol 2017;3:013005. [DOI: 10.1088/2057-1739/aa5beb] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
581 Hanada K, Okazaki A, Hirano N, Izumi Y, Minami T, Ikemoto J, Kanemitsu K, Hino F. Effective screening for early diagnosis of pancreatic cancer. Best Pract Res Clin Gastroenterol 2015;29:929-39. [PMID: 26651254 DOI: 10.1016/j.bpg.2015.09.017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
582 Wang S, Zheng Y, Yang F, Zhu L, Zhu XQ, Wang ZF, Wu XL, Zhou CH, Yan JY, Hu BY, Kong B, Fu DL, Bruns C, Zhao Y, Qin LX, Dong QZ. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduct Target Ther 2021;6:249. [PMID: 34219130 DOI: 10.1038/s41392-021-00659-4] [Reference Citation Analysis]
583 Tjensvoll K, Lapin M, Buhl T, Oltedal S, Steen-Ottosen Berry K, Gilje B, Søreide JA, Javle M, Nordgård O, Smaaland R. Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer. Mol Oncol 2016;10:635-43. [PMID: 26725968 DOI: 10.1016/j.molonc.2015.11.012] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 12.3] [Reference Citation Analysis]
584 Keenan BP, Saenger Y, Kafrouni MI, Leubner A, Lauer P, Maitra A, Rucki AA, Gunderson AJ, Coussens LM, Brockstedt DG. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice. Gastroenterology. 2014;146:1784-94.e6. [PMID: 24607504 DOI: 10.1053/j.gastro.2014.02.055] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 9.5] [Reference Citation Analysis]
585 Pang Y, Holmes MV, Kartsonaki C, Guo Y, Yang L, Bian Z, Chen Y, Bragg F, Iona A, Millwood IY, Chen J, Li L, Chen Z. Young adulthood and adulthood adiposity in relation to incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis. J Epidemiol Community Health 2017;71:1059-67. [PMID: 28900029 DOI: 10.1136/jech-2017-208895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
586 Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013;501:338-345. [PMID: 24048066 DOI: 10.1038/nature12625] [Cited by in Crossref: 1320] [Cited by in F6Publishing: 1151] [Article Influence: 146.7] [Reference Citation Analysis]
587 Iovanna J, Mallmann MC, Gonçalves A, Turrini O, Dagorn JC. Current knowledge on pancreatic cancer. Front Oncol. 2012;2:6. [PMID: 22655256 DOI: 10.3389/fonc.2012.00006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
588 Romei C, Ciampi R, Casella F, Tacito A, Torregrossa L, Ugolini C, Basolo F, Materazzi G, Vitti P, Elisei R. RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases. Oncotarget 2018;9:9875-84. [PMID: 29515777 DOI: 10.18632/oncotarget.23986] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
589 Sahin IH, Lowery MA, Stadler ZK, Salo-Mullen E, Iacobuzio-Donahue CA, Kelsen DP, O'Reilly EM. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches. Expert Rev Gastroenterol Hepatol. 2016;10:893-905. [PMID: 26881472 DOI: 10.1586/17474124.2016.1153424] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
590 Wang D, Liu C, Zhou Y, Yan T, Li C, Yang Q, Xu Y, Zhao L, Pei Q, Tan F, Güngör C, Li Y. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis. Radiat Oncol 2020;15:107. [PMID: 32404114 DOI: 10.1186/s13014-020-01561-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
591 Valetti S, Maione F, Mura S, Stella B, Desmaële D, Noiray M, Vergnaud J, Vauthier C, Cattel L, Giraudo E, Couvreur P. Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. J Control Release 2014;192:29-39. [PMID: 24984010 DOI: 10.1016/j.jconrel.2014.06.039] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
592 McCoach CE, Bivona TG. Engineering Multidimensional Evolutionary Forces to Combat Cancer. Cancer Discov 2019;9:587-604. [PMID: 30992280 DOI: 10.1158/2159-8290.CD-18-1196] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
593 Evers L, Perez-Mancera PA, Lenkiewicz E, Tang N, Aust D, Knösel T, Rümmele P, Holley T, Kassner M, Aziz M, Ramanathan RK, Von Hoff DD, Yin H, Pilarsky C, Barrett MT. STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma. Genome Med 2014;6:9. [PMID: 24484537 DOI: 10.1186/gm526] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
594 Faratian D, Christiansen J, Gustavson M, Jones C, Scott C, Um I, Harrison DJ. Heterogeneity mapping of protein expression in tumors using quantitative immunofluorescence. J Vis Exp 2011;:e3334. [PMID: 22064683 DOI: 10.3791/3334] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
595 Baslan T, Kendall J, Rodgers L, Cox H, Riggs M, Stepansky A, Troge J, Ravi K, Esposito D, Lakshmi B, Wigler M, Navin N, Hicks J. Genome-wide copy number analysis of single cells. Nat Protoc 2012;7:1024-41. [PMID: 22555242 DOI: 10.1038/nprot.2012.039] [Cited by in Crossref: 230] [Cited by in F6Publishing: 195] [Article Influence: 23.0] [Reference Citation Analysis]
596 Ventura R, Mordec K, Waszczuk J, Wang Z, Lai J, Fridlib M, Buckley D, Kemble G, Heuer TS. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression. EBioMedicine 2015;2:808-24. [PMID: 26425687 DOI: 10.1016/j.ebiom.2015.06.020] [Cited by in Crossref: 106] [Cited by in F6Publishing: 109] [Article Influence: 15.1] [Reference Citation Analysis]
597 Gatenby RA, Grove O, Gillies RJ. Quantitative imaging in cancer evolution and ecology. Radiology. 2013;269:8-15. [PMID: 24062559 DOI: 10.1148/radiol.13122697] [Cited by in Crossref: 226] [Cited by in F6Publishing: 205] [Article Influence: 25.1] [Reference Citation Analysis]
598 Dakhel S, Padilla L, Adan J, Masa M, Martinez JM, Roque L, Coll T, Hervas R, Calvis C, Messeguer R, Mitjans F, Hernández JL. S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer. Oncogenesis 2014;3:e92. [PMID: 24637492 DOI: 10.1038/oncsis.2014.7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
599 Wang Y, Li Z, Zheng S, Zhou Y, Zhao L, Ye H, Zhao X, Gao W, Fu Z, Zhou Q, Liu Y, Chen R. Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. Oncotarget 2015;6:35684-98. [PMID: 26447755 DOI: 10.18632/oncotarget.5533] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 9.5] [Reference Citation Analysis]
600 Ruiz C, Li J, Luttgen MS, Kolatkar A, Kendall JT, Flores E, Topp Z, Samlowski WE, McClay E, Bethel K, Ferrone S, Hicks J, Kuhn P. Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients. Phys Biol 2015;12:016008. [PMID: 25574741 DOI: 10.1088/1478-3975/12/1/016008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
601 Sun R, Nikolakopoulos AN. Elements and evolutionary determinants of genomic divergence between paired primary and metastatic tumors. PLoS Comput Biol 2021;17:e1008838. [PMID: 33730105 DOI: 10.1371/journal.pcbi.1008838] [Reference Citation Analysis]
602 Niida A, Nagayama S, Miyano S, Mimori K. Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling. Cancer Sci 2018;109:884-92. [PMID: 29352488 DOI: 10.1111/cas.13510] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
603 Thompson AM, Smith JL, Monroe LD, Kreutz JE, Schneider T, Fujimoto BS, Chiu DT, Radich JP, Paguirigan AL. Self-digitization chip for single-cell genotyping of cancer-related mutations. PLoS One 2018;13:e0196801. [PMID: 29718986 DOI: 10.1371/journal.pone.0196801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
604 Erkan M, Hausmann S, Michalski CW, Schlitter AM, Fingerle AA, Dobritz M, Friess H, Kleeff J. How fibrosis influences imaging and surgical decisions in pancreatic cancer. Front Physiol. 2012;3:389. [PMID: 23060813 DOI: 10.3389/fphys.2012.00389] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
605 Lüönd F, Tiede S, Christofori G. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. Br J Cancer 2021;125:164-75. [PMID: 33824479 DOI: 10.1038/s41416-021-01328-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
606 Roato I, Ferracini R. Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases. Cancers (Basel). 2018;10:pii: E56. [PMID: 29461491 DOI: 10.3390/cancers10020056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
607 Singovski G, Bernal C, Kuciak M, Siegl-Cachedenier I, Conod A, Ruiz i Altaba A. In vivo epigenetic reprogramming of primary human colon cancer cells enhances metastases. J Mol Cell Biol 2016;8:157-73. [PMID: 26031752 DOI: 10.1093/jmcb/mjv034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
608 Furnari FB, Cloughesy TF, Cavenee WK, Mischel PS. Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma. Nat Rev Cancer 2015;15:302-10. [PMID: 25855404 DOI: 10.1038/nrc3918] [Cited by in Crossref: 204] [Cited by in F6Publishing: 185] [Article Influence: 29.1] [Reference Citation Analysis]
609 Matthaei H, Dal Molin M, Maitra A. Identification and analysis of precursors to invasive pancreatic cancer. Methods Mol Biol 2013;980:1-12. [PMID: 23359146 DOI: 10.1007/978-1-62703-287-2_1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
610 Beckman RA, Yeang CH. Nonstandard personalized medicine strategies for cancer may lead to improved patient outcomes. Per Med 2014;11:705-19. [PMID: 29764056 DOI: 10.2217/pme.14.57] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
611 Mascitti M, Togni L, Troiano G, Caponio VCA, Gissi DB, Montebugnoli L, Procaccini M, Lo Muzio L, Santarelli A. Beyond Head and Neck Cancer: The Relationship Between Oral Microbiota and Tumour Development in Distant Organs. Front Cell Infect Microbiol 2019;9:232. [PMID: 31297343 DOI: 10.3389/fcimb.2019.00232] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
612 Serrao EM, Kettunen MI, Rodrigues TB, Dzien P, Wright AJ, Gopinathan A, Gallagher FA, Lewis DY, Frese KK, Almeida J, Howat WJ, Tuveson DA, Brindle KM. MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model. Gut 2016;65:465-75. [PMID: 26347531 DOI: 10.1136/gutjnl-2015-310114] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
613 Zhou X, Ye M, Han Y, Tang J, Qian Y, Hu H, Shen Y. Enhancing MRI of liver metastases with a zwitterionized biodegradable dendritic contrast agent. Biomater Sci 2017;5:1588-95. [DOI: 10.1039/c7bm00126f] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 2.6] [Reference Citation Analysis]
614 Ramos P, Bentires-Alj M. Mechanism-based cancer therapy: resistance to therapy, therapy for resistance. Oncogene. 2014;Epub ahead of print. [PMID: 25263438 DOI: 10.1038/onc.2014.314] [Cited by in Crossref: 138] [Cited by in F6Publishing: 128] [Article Influence: 17.3] [Reference Citation Analysis]
615 Carbone C, Piro G, Fassan M, Tamburrino A, Mina MM, Zanotto M, Chiao PJ, Bassi C, Scarpa A, Tortora G, Melisi D. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis. Oncotarget 2015;6:13822-34. [PMID: 25360865 DOI: 10.18632/oncotarget.2635] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
616 Makohon-Moore AP, Matsukuma K, Zhang M, Reiter JG, Gerold JM, Jiao Y, Sikkema L, Attiyeh MA, Yachida S, Sandone C, Hruban RH, Klimstra DS, Papadopoulos N, Nowak MA, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA. Precancerous neoplastic cells can move through the pancreatic ductal system. Nature 2018;561:201-5. [PMID: 30177826 DOI: 10.1038/s41586-018-0481-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 11.8] [Reference Citation Analysis]
617 Li Y, Luo Y. Performance-weighted-voting model: An ensemble machine learning method for cancer type classification using whole-exome sequencing mutation. Quant Biol 2020;8:347-58. [PMID: 34336363 DOI: 10.1007/s40484-020-0226-1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
618 Zhou YF, Xu LX, Huang LY, Guo F, Zhang F, He XY, Yuan YZ, Yao WY. Combined detection of serum UL16-binding protein 2 and macrophage inhibitory cytokine-1 improves early diagnosis and prognostic prediction of pancreatic cancer. Oncol Lett. 2014;8:2096-2102. [PMID: 25295097 DOI: 10.3892/ol.2014.2429] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
619 Mayers JR. Metabolic markers as cancer clues. Science 2017;358:1265. [PMID: 29217564 DOI: 10.1126/science.aar2001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
620 Zong C, Lu S, Chapman AR, Xie XS. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 2012;338:1622-6. [PMID: 23258894 DOI: 10.1126/science.1229164] [Cited by in Crossref: 674] [Cited by in F6Publishing: 588] [Article Influence: 74.9] [Reference Citation Analysis]
621 Vilhav C, Engström C, Naredi P, Novotny A, Bourghardt-Fagman J, Iresjö BM, Asting AG, Lundholm K. Fractional uptake of circulating tumor cells into liver-lung compartments during curative resection of periampullary cancer. Oncol Lett 2018;16:6331-8. [PMID: 30405768 DOI: 10.3892/ol.2018.9435] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
622 Iacobuzio-Donahue CA, Michael C, Baez P, Kappagantula R, Hooper JE, Hollman TJ. Cancer biology as revealed by the research autopsy. Nat Rev Cancer 2019;19:686-97. [PMID: 31519982 DOI: 10.1038/s41568-019-0199-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
623 Mroz EA, Tward AD, Pickering CR, Myers JN, Ferris RL, Rocco JW. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer 2013;119:3034-42. [PMID: 23696076 DOI: 10.1002/cncr.28150] [Cited by in Crossref: 123] [Cited by in F6Publishing: 122] [Article Influence: 13.7] [Reference Citation Analysis]
624 Miyazaki T, Aishima S, Fujino M, Ozono K, Kubo Y, Ushijima Y, Osoegawa T, Ihara E, Tetsuhide I, Ohtsuka T, Nakamura M, Oda Y. Neuroendocrine tumor of the pancreas with rhabdoid feature. Virchows Arch 2018;473:247-52. [PMID: 29938394 DOI: 10.1007/s00428-018-2398-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
625 Lowery MA, O'Reilly EM. New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy. BioDrugs 2011;25:207-16. [PMID: 21815696 DOI: 10.2165/11592470-000000000-00000] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
626 Zhao B, Hemann MT, Lauffenburger DA. Modeling Tumor Clonal Evolution for Drug Combinations Design. Trends Cancer 2016;2:144-58. [PMID: 28435907 DOI: 10.1016/j.trecan.2016.02.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
627 Zhang N, Di J, Wang Z, Gao P, Jiang B, Su X. Genomic profiling of colorectal cancer with isolated lung metastasis. Cancer Cell Int 2020;20:281. [PMID: 32624706 DOI: 10.1186/s12935-020-01373-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
628 Daoud AZ, Mulholland EJ, Cole G, McCarthy HO. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.BMC Cancer. 2019;19:1130. [PMID: 31752758 DOI: 10.1186/s12885-019-6284-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
629 Sherman M, Bruix J. Biopsy for liver cancer: how to balance research needs with evidence-based clinical practice. Hepatology. 2015;61:433-436. [PMID: 25308482 DOI: 10.1002/hep.27563] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
630 Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. Surgery. 2019;166:277-285. [PMID: 31272811 DOI: 10.1016/j.surg.2019.05.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
631 Udgata S, Takenaka N, Bamlet WR, Oberg AL, Yee SS, Carpenter EL, Herman D, Kim J, Petersen GM, Zaret KS. THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement. Cancer Prev Res (Phila) 2021;14:223-32. [PMID: 33067248 DOI: 10.1158/1940-6207.CAPR-20-0403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
632 Mccullough ML, Jacobs EJ, Shah R, Campbell PT, Wang Y, Hartman TJ, Gapstur SM. Meat consumption and pancreatic cancer risk among men and women in the Cancer Prevention Study-II Nutrition Cohort. Cancer Causes Control 2018;29:125-33. [DOI: 10.1007/s10552-017-0984-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
633 Ying H, Dey P, Yao W, Kimmelman AC, Draetta GF, Maitra A, DePinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2016;30:355-385. [PMID: 26883357 DOI: 10.1101/gad.275776.115] [Cited by in Crossref: 241] [Cited by in F6Publishing: 226] [Article Influence: 40.2] [Reference Citation Analysis]
634 Martinez P, Mallo D, Paulson TG, Li X, Sanchez CA, Reid BJ, Graham TA, Kuhner MK, Maley CC. Evolution of Barrett's esophagus through space and time at single-crypt and whole-biopsy levels. Nat Commun 2018;9:794. [PMID: 29476056 DOI: 10.1038/s41467-017-02621-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
635 Morran DC, Wu J, Jamieson NB, Mrowinska A, Kalna G, Karim SA, Au AY, Scarlett CJ, Chang DK, Pajak MZ. Targeting mTOR dependency in pancreatic cancer. Gut. 2014;63:1481-1489. [PMID: 24717934 DOI: 10.1136/gutjnl-2013-306202] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
636 McDonald OG, Li X, Saunders T, Tryggvadottir R, Mentch SJ, Warmoes MO, Word AE, Carrer A, Salz TH, Natsume S, Stauffer KM, Makohon-Moore A, Zhong Y, Wu H, Wellen KE, Locasale JW, Iacobuzio-Donahue CA, Feinberg AP. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Nat Genet 2017;49:367-76. [PMID: 28092686 DOI: 10.1038/ng.3753] [Cited by in Crossref: 210] [Cited by in F6Publishing: 187] [Article Influence: 42.0] [Reference Citation Analysis]
637 De Jesus-Acosta A, Oliver GR, Blackford A, Kinsman K, Flores EI, Wilfong LS, Zheng L, Donehower RC, Cosgrove D, Laheru D. A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma. Cancer Chemother Pharmacol. 2012;69:415-424. [PMID: 21800112 DOI: 10.1007/s00280-011-1704-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
638 Gillies RJ, Gatenby RA. Metabolism and its sequelae in cancer evolution and therapy. Cancer J 2015;21:88-96. [PMID: 25815848 DOI: 10.1097/PPO.0000000000000102] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 7.1] [Reference Citation Analysis]
639 Vondenberg JA, Muruganandam M, Nunez SE, Emil NS, Sibbitt WL Jr. Increased malignancies in systemic sclerosis. Int J Rheum Dis 2022;25:90-2. [PMID: 34779580 DOI: 10.1111/1756-185X.14244] [Reference Citation Analysis]
640 Xie QY, Almudevar A, Whitney-Miller CL, Barry CT, McCall MN. A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity. BMC Med Genomics 2016;9:18. [PMID: 27059462 DOI: 10.1186/s12920-016-0179-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
641 Martin-Romano P, Adam J, Scoazec JY, Gouy S, Levy A, Baldini C, Champiat S, Soria JC, Massard C, Marabelle A, Deutsch E, Hollebecque A. Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker? Front Immunol 2021;12:745146. [PMID: 34804027 DOI: 10.3389/fimmu.2021.745146] [Reference Citation Analysis]
642 Nauck MA. A critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risks. Diabetes Care. 2013;36:2126-2132. [PMID: 23645884 DOI: 10.2337/dc12-2504] [Cited by in Crossref: 144] [Cited by in F6Publishing: 127] [Article Influence: 16.0] [Reference Citation Analysis]
643 Albury TM, Pandey V, Gitto SB, Dominguez L, Spinel LP, Talarchek J, Klein-Szanto AJ, Testa JR, Altomare DA. Constitutively active Akt1 cooperates with KRas(G12D) to accelerate in vivo pancreatic tumor onset and progression. Neoplasia 2015;17:175-82. [PMID: 25748236 DOI: 10.1016/j.neo.2014.12.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
644 Heemskerk B, Kvistborg P, Schumacher TN. The cancer antigenome. EMBO J 2013;32:194-203. [PMID: 23258224 DOI: 10.1038/emboj.2012.333] [Cited by in Crossref: 162] [Cited by in F6Publishing: 153] [Article Influence: 16.2] [Reference Citation Analysis]
645 Richard V, Kumar TRS, Pillai RM. Transitional dynamics of cancer stem cells in invasion and metastasis. Transl Oncol 2021;14:100909. [PMID: 33049522 DOI: 10.1016/j.tranon.2020.100909] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
646 Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, Wolfgang CL, Schulick RD, Langfield L, Andruss BF, Adai AT, Hruban RH, Szafranska-Schwarzbach AE, Maitra A. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res. 2012;18:4713-4724. [PMID: 22723372 DOI: 10.1158/1078-0432.ccr-12-0035] [Cited by in Crossref: 107] [Cited by in F6Publishing: 67] [Article Influence: 10.7] [Reference Citation Analysis]
647 Jiang W, Bai W, Li J, Liu J, Zhao K, Ren L. Leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer. Int J Cancer 2021;148:1006-13. [PMID: 32914874 DOI: 10.1002/ijc.33291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
648 Al Dhaheri Y, Attoub S, Arafat K, Abuqamar S, Viallet J, Saleh A, Al Agha H, Eid A, Iratni R. Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NFκB signaling and reduction of nitric oxide production. PLoS One 2013;8:e68808. [PMID: 23874773 DOI: 10.1371/journal.pone.0068808] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
649 Wood LD. Pancreatic cancer genomes: toward molecular subtyping and novel approaches to diagnosis and therapy. Mol Diagn Ther 2013;17:287-97. [PMID: 23757204 DOI: 10.1007/s40291-013-0043-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
650 Engels B, Gevaert T, Everaert H, De Coninck P, Sermeus A, Christian N, Storme G, Verellen D, De Ridder M. Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer. Radiat Oncol 2012;7:34. [PMID: 22423615 DOI: 10.1186/1748-717X-7-34] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
651 Joshi A, Göttgens B. Maximum parsimony analysis of gene expression profiles permits the reconstruction of developmental cell lineage trees. Dev Biol 2011;353:440-7. [PMID: 21354129 DOI: 10.1016/j.ydbio.2011.02.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
652 Hochberg ME. An ecosystem framework for understanding and treating disease. Evol Med Public Health 2018;2018:270-86. [PMID: 30487969 DOI: 10.1093/emph/eoy032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
653 Palamaris K, Felekouras E, Sakellariou S. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance. Cancers (Basel) 2021;13:5532. [PMID: 34771695 DOI: 10.3390/cancers13215532] [Reference Citation Analysis]
654 Hwang CI, Boj SF, Clevers H, Tuveson DA. Preclinical models of pancreatic ductal adenocarcinoma. J Pathol. 2016;238:197-204. [PMID: 26419819 DOI: 10.1002/path.4651] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
655 Wada K, Takaori K, Traverso LW. Screening for Pancreatic Cancer. Surg Clin North Am. 2015;95:1041-1052. [PMID: 26315522 DOI: 10.1016/j.suc.2015.05.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
656 Zhao Y, Dong Q, Li J, Zhang K, Qin J, Zhao J, Sun Q, Wang Z, Wartmann T, Jauch KW, Nelson PJ, Qin L, Bruns C. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies. Semin Cancer Biol. 2018;53:139-155. [PMID: 30081228 DOI: 10.1016/j.semcancer.2018.08.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 13.8] [Reference Citation Analysis]
657 Ducreux M, Cuhna AS, Caramella C, Hollebecque A, Burtin P, Goéré D, Seufferlein T, Haustermans K, Van Laethem J, Conroy T, Arnold D. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2015;26:v56-68. [DOI: 10.1093/annonc/mdv295] [Cited by in Crossref: 525] [Cited by in F6Publishing: 477] [Article Influence: 75.0] [Reference Citation Analysis]
658 Paguirigan AL, Smith J, Meshinchi S, Carroll M, Maley C, Radich JP. Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia. Sci Transl Med 2015;7:281re2. [PMID: 25834112 DOI: 10.1126/scitranslmed.aaa0763] [Cited by in Crossref: 109] [Cited by in F6Publishing: 94] [Article Influence: 15.6] [Reference Citation Analysis]
659 Kanno A, Masamune A, Hanada K, Maguchi H, Shimizu Y, Ueki T, Hasebe O, Ohtsuka T, Nakamura M, Takenaka M, Kitano M, Kikuyama M, Gabata T, Yoshida K, Sasaki T, Serikawa M, Furukawa T, Yanagisawa A, Shimosegawa T;  Japan Study Group on the Early Detection of Pancreatic Cancer (JEDPAC). Multicenter study of early pancreatic cancer in Japan. Pancreatology. 2018;18:61-67. [PMID: 29170051 DOI: 10.1016/j.pan.2017.11.007] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
660 Mian SA, Bonnet D. Nature or Nurture? Role of the Bone Marrow Microenvironment in the Genesis and Maintenance of Myelodysplastic Syndromes. Cancers (Basel) 2021;13:4116. [PMID: 34439269 DOI: 10.3390/cancers13164116] [Reference Citation Analysis]
661 Gharibi A, La Kim S, Molnar J, Brambilla D, Adamian Y, Hoover M, Hong J, Lin J, Wolfenden L, Kelber JA. ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. Sci Rep 2017;7:10060. [PMID: 28855593 DOI: 10.1038/s41598-017-09946-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
662 Risch HA. Diabetes and Pancreatic Cancer: Both Cause and Effect. J Natl Cancer Inst 2019;111:1-2. [PMID: 29917095 DOI: 10.1093/jnci/djy093] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
663 Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559-1564. [PMID: 21436443 DOI: 10.1126/science.1203543] [Cited by in Crossref: 2631] [Cited by in F6Publishing: 2544] [Article Influence: 239.2] [Reference Citation Analysis]
664 Hasan S, Jacob R, Manne U, Paluri R. Advances in pancreatic cancer biomarkers. Oncol Rev 2019;13:410. [PMID: 31044028 DOI: 10.4081/oncol.2019.410] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 13.0] [Reference Citation Analysis]
665 McIntyre CA, Winter JM. Diagnostic evaluation and staging of pancreatic ductal adenocarcinoma. Semin Oncol 2015;42:19-27. [PMID: 25726049 DOI: 10.1053/j.seminoncol.2014.12.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
666 Arpalahti L, Haglund C, Holmberg CI. Proteostasis Dysregulation in Pancreatic Cancer. Adv Exp Med Biol 2020;1233:101-15. [PMID: 32274754 DOI: 10.1007/978-3-030-38266-7_4] [Reference Citation Analysis]
667 Woodcock DJ, Riabchenko E, Taavitsainen S, Kankainen M, Gundem G, Brewer DS, Ellonen P, Lepistö M, Golubeva YA, Warner AC, Tolonen T, Jasu J, Isaacs WB, Emmert-Buck MR, Nykter M, Visakorpi T, Bova GS, Wedge DC. Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy. Nat Commun 2020;11:5070. [PMID: 33033260 DOI: 10.1038/s41467-020-18843-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
668 Kim EY, Lee SH, Kim A, Kim T, Chang YS. Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation. J Cancer 2019;10:5549-56. [PMID: 31632498 DOI: 10.7150/jca.32897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
669 Gregorc V, Lazzari C, Mandalá M, Ippati S, Bulotta A, Cangi MG, Khater A, Viganò MG, Mirabile A, Pecciarini L, Ogliari FR, Arrigoni G, Grassini G, Veronesi G, Doglioni C. Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:2023. [PMID: 33922215 DOI: 10.3390/cancers13092023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
670 Shibata D. Cancer. Heterogeneity and tumor history. Science 2012;336:304-5. [PMID: 22517848 DOI: 10.1126/science.1222361] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
671 Shibata K, Omahdi Z, Yamasaki S. Necroptosis DAMPens anti-tumor immunity. Cell Death Discov 2016;2:16033. [PMID: 27551523 DOI: 10.1038/cddiscovery.2016.33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
672 Tang D, Kroemer G, Kang R. Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges. Mol Cancer 2021;20:128. [PMID: 34607583 DOI: 10.1186/s12943-021-01422-7] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
673 Apostoli AJ, Ailles L. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment. Crit Rev Clin Lab Sci 2016;53:40-51. [PMID: 26397062 DOI: 10.3109/10408363.2015.1083944] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
674 Hruban RH. Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News. Pancreas 2019;48:591-3. [PMID: 31090658 DOI: 10.1097/MPA.0000000000001299] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
675 Echeverria GV, Powell E, Seth S, Ge Z, Carugo A, Bristow C, Peoples M, Robinson F, Qiu H, Shao J, Jeter-Jones SL, Zhang X, Ramamoorthy V, Cai S, Wu W, Draetta G, Moulder SL, Symmans WF, Chang JT, Heffernan TP, Piwnica-Worms H. High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer. Nat Commun 2018;9:5079. [PMID: 30498242 DOI: 10.1038/s41467-018-07406-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
676 Zhang L, Kim S, Ding W, Tong Y, Zhang X, Pan M, Chen S. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo. Drug Des Devel Ther 2015;9:5579-90. [PMID: 26487802 DOI: 10.2147/DDDT.S89805] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
677 Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES, Getz G. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 2013;31:213-9. [PMID: 23396013 DOI: 10.1038/nbt.2514] [Cited by in Crossref: 2631] [Cited by in F6Publishing: 2295] [Article Influence: 292.3] [Reference Citation Analysis]
678 Mohammed A, Janakiram NB, Madka V, Pathuri G, Li Q, Ritchie R, Biddick L, Kutche H, Zhang Y, Singh A, Gali H, Lightfoot S, Steele VE, Suen CS, Rao CV. Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer. Oncotarget 2017;8:97822-34. [PMID: 29228654 DOI: 10.18632/oncotarget.22085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
679 Kinny-Köster B, Habib JR, Wolfgang CL, He J, Javed AA. Favorable tumor biology in locally advanced pancreatic cancer-beyond CA19-9. J Gastrointest Oncol 2021;12:2484-94. [PMID: 34790409 DOI: 10.21037/jgo-20-426] [Reference Citation Analysis]
680 Bao Z, Wang Y, Wang Q, Fang S, Shan X, Wang J, Jiang T. Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution. Front Med 2021;15:551-61. [PMID: 33893983 DOI: 10.1007/s11684-020-0760-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article